Expression	O
status	O
of	O
BCL-6	B-protein
and	O
syndecan-1	B-protein
identifies	O
distinct	O
histogenetic	O
subtypes	O
of	O
Hodgkin	O
's	O
disease	O
.	O

The	O
tumor	B-cell_type
cells	I-cell_type
in	O
most	O
cases	O
of	O
Hodgkin	O
's	O
disease	O
(	O
HD	O
)	O
have	O
been	O
recently	O
recognized	O
to	O
originate	O
from	O
the	O
B-cell	B-cell_type
lineage	I-cell_type
,	O
but	O
their	O
precise	O
differentiation	O
stage	O
is	O
not	O
fully	O
clarified	O
.	O

Recently	O
,	O
we	O
have	O
reported	O
that	O
the	O
histogenesis	O
of	O
B-cell	B-cell_type
lymphomas	I-cell_type
may	O
be	O
assessed	O
by	O
monitoring	O
the	O
expression	O
pattern	O
of	O
BCL-6	B-protein
,	O
a	O
transcription	B-protein
factor	I-protein
expressed	O
in	O
germinal	B-cell_type
center	I-cell_type
(	I-cell_type
GC	I-cell_type
)	I-cell_type
B	I-cell_type
cells	I-cell_type
,	O
and	O
CD138/syndecan-1	B-protein
(	O
syn-1	B-protein
)	O
,	O
a	O
proteoglycan	O
associated	O
with	O
post-GC	O
,	O
terminal	O
B-cell	O
differentiation	O
.	O

In	O
this	O
study	O
,	O
we	O
have	O
applied	O
these	O
two	O
markers	O
to	O
the	O
study	O
of	O
HD	O
histogenesis	O
.	O

We	O
have	O
found	O
that	O
in	O
nodular	O
lymphocyte	O
predominance	O
HD	O
(	O
NLPHD	O
)	O
tumor	B-cell_type
cells	I-cell_type
consistently	O
display	O
the	O
BCL-6	B-protein
(	O
+	O
)	O
/	O
syn-1	B-protein
(	O
-	O
)	O
phenotype	O
,	O
indicating	O
their	O
derivation	O
from	O
GC	B-cell_type
B	I-cell_type
cells	I-cell_type
.	O

Conversely	O
,	O
classic	O
HD	O
(	O
CHD	O
)	O
is	O
heterogeneous	O
because	O
the	O
tumor	B-cell_type
cells	I-cell_type
of	O
a	O
fraction	O
of	O
CHD	O
display	O
the	O
BCL-6	B-protein
(	O
-	O
)	O
/	O
syn-1	B-protein
(	O
+	O
)	O
phenotype	O
of	O
post-GC	O
B-cells	O
,	O
whereas	O
another	O
fraction	O
of	O
CHD	O
is	O
constituted	O
by	O
a	O
mixture	O
of	O
tumor	B-cell_type
cells	I-cell_type
reflecting	O
the	O
GC	O
(	O
BCL-6	B-protein
(	O
+	O
)	O
/	O
syn-1	B-protein
(	O
-	O
)	O
)	O
or	O
post-GC	O
(	O
BCL-6	B-protein
(	O
-	O
)	O
/	O
syn-1	B-protein
(	O
+	O
)	O
)	O
phenotypes	O
.	O

BCL-6	B-cell_line
(	I-cell_line
-	I-cell_line
)	I-cell_line
/syn-1	I-cell_line
(	I-cell_line
+	I-cell_line
)	I-cell_line
tumor	I-cell_line
cells	I-cell_line
of	O
CHD	O
are	O
mostly	O
found	O
surrounded	O
by	O
T	B-cell_type
cells	I-cell_type
expressing	O
CD40L	B-protein
,	O
consistent	O
with	O
the	O
observation	O
that	O
CD40	B-protein
signaling	O
downregulates	O
BCL-6	B-protein
expression	O
.	O

These	O
data	O
indicate	O
that	O
tumor	B-cell_type
cells	I-cell_type
of	O
NLPHD	O
uniformly	O
display	O
a	O
GC	O
B-cell	O
phenotype	O
,	O
whereas	O
the	O
phenotype	O
of	O
tumor	B-cell_type
cells	I-cell_type
of	O
CHD	O
appears	O
to	O
be	O
modulated	O
by	O
the	O
surrounding	O
cellular	O
background	O
,	O
particularly	O
CD40L+	B-cell_type
reactive	I-cell_type
T	I-cell_type
cells	I-cell_type
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

RAPID	NULL
COMMUNICATION	NULL
Expression	NULL
Status	NULL
of	NULL
BCL-6	NULL
and	NULL
Syndecan-1	NULL
Identifies	NULL
Distinct	NULL
Histogenetic	NULL
Subtypes	NULL
of	NULL
Hodgkin	NULL
's	NULL
Disease	NULL
By	NULL
Antonino	NULL
Carbone	NULL
,	NULL
Annunziata	NULL
Gloghini	NULL
,	NULL
Gianluca	NULL
Gaidano	NULL
,	NULL
Silvia	NULL
Franceschi	NULL
,	NULL
Daniela	NULL
Capello	NULL
,	NULL
Hans	NULL
G.	NULL
Drexler	NULL
,	NULL
Brunangelo	NULL
Falini	NULL
,	NULL
and	NULL
Riccardo	NULL
Dalla-Favera	NULL
The	NULL
tumor	NULL
cells	NULL
in	NULL
most	NULL
cases	NULL
of	NULL
Hodgkin	NULL
's	NULL
disease	NULL
(	NULL
HD	NULL
)	NULL
have	NULL
been	NULL
recently	NULL
recognized	NULL
to	NULL
originate	NULL
from	NULL
the	NULL
B-cell	NULL
lineage	NULL
,	NULL
but	NULL
their	NULL
precise	NULL
differentiation	NULL
stage	NULL
is	NULL
not	NULL
fully	NULL
clarified	NULL
.	NULL

Recently	NULL
,	NULL
we	NULL
have	NULL
reported	NULL
that	NULL
the	NULL
histogenesis	NULL
of	NULL
B-cell	NULL
lymphomas	NULL
may	NULL
be	NULL
assessed	NULL
by	NULL
monitoring	NULL
the	NULL
expression	NULL
pattern	NULL
of	NULL
BCL-6	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
expressed	NULL
in	NULL
germinal	NULL
center	NULL
(	NULL
GC	NULL
)	NULL
B	NULL
cells	NULL
,	NULL
and	NULL
CD138/	NULL
syndecan-1	NULL
(	NULL
syn-1	NULL
)	NULL
,	NULL
a	NULL
proteoglycan	NULL
associated	NULL
with	NULL
post-GC	NULL
,	NULL
terminal	NULL
B-cell	NULL
differentiation	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
applied	NULL
these	NULL
tw	NULL
o	NULL
markers	NULL
to	NULL
the	NULL
study	NULL
of	NULL
HD	NULL
histogenesis	NULL
.	NULL

We	NULL
have	NULL
found	NULL
that	NULL
in	NULL
nodular	NULL
lymphocyte	NULL
predominance	NULL
HD	NULL
(	NULL
NLPHD	NULL
)	NULL
tumor	NULL
cells	NULL
consistently	NULL
display	NULL
the	NULL
BCL-6+/syn-1~	NULL
phenotype	NULL
,	NULL
indicating	NULL
their	NULL
derivation	NULL
from	NULL
GC	NULL
B	NULL
cells	NULL
.	NULL

Conversely	NULL
,	NULL
classic	NULL
HD	NULL
(	NULL
CHD	NULL
)	NULL
is	NULL
ODGKIN®S	NULL
DISEASE	NULL
(	NULL
HD	NULL
)	NULL
is	NULL
characterized	NULL
histologi-cally	NULL
by	NULL
scanty	NULL
neoplastic	NULL
cells	NULL
interspersed	NULL
in	NULL
the	NULL
context	NULL
of	NULL
a	NULL
reactive	NULL
cellular	NULL
background	NULL
.	NULL
``	NULL

''	NULL
Based	NULL
on	NULL
the	NULL
characteristics	NULL
of	NULL
neoplastic	NULL
cells	NULL
and	NULL
of	NULL
the	NULL
reactive	NULL
background	NULL
,	NULL
HD	NULL
is	NULL
distinguished	NULL
into	NULL
two	NULL
major	NULL
categories	NULL
termed	NULL
nodular	NULL
lymphocyte	NULL
predominance	NULL
HD	NULL
(	NULL
NLPHD	NULL
)	NULL
and	NULL
classic	NULL
HD	NULL
(	NULL
CHD	NULL
)	NULL
.	NULL

Whereas	NULL
NLPHD	NULL
generally	NULL
follows	NULL
an	NULL
indolent	NULL
course	NULL
,	NULL
CHD	NULL
is	NULL
fatal	NULL
without	NULL
therapy.3*	NULL
The	NULL
detailed	NULL
characterization	NULL
of	NULL
the	NULL
HD	NULL
neoplastic	NULL
population	NULL
has	NULL
been	NULL
a	NULL
matter	NULL
of	NULL
debate	NULL
for	NULL
many	NULL
years	NULL
.	NULL
``	NULL

Recently	NULL
,	NULL
single-cell	NULL
analysis	NULL
of	NULL
Ig	NULL
genes	NULL
has	NULL
shown	NULL
that	NULL
tumor	NULL
cells	NULL
of	NULL
NLPHD	NULL
and	NULL
of	NULL
most	NULL
CHD	NULL
of	NULL
B-cell	NULL
lineage	NULL
derive	NULL
from	NULL
germinal	NULL
center	NULL
(	NULL
GC	NULL
)	NULL
B	NULL
cells	NULL
that	NULL
have	NULL
been	NULL
stimulated	NULL
and	NULL
selected	NULL
by	NULL
antigen	NULL
.	NULL
``	NULL

''	NULL
Despite	NULL
their	NULL
common	NULL
origin	NULL
,	NULL
however	NULL
,	NULL
neoplastic	NULL
cells	NULL
of	NULL
CHD	NULL
,	NULL
known	NULL
as	NULL
Reed-Sternberg	NULL
(	NULL
RS	NULL
)	NULL
cells	NULL
,	NULL
From	NULL
the	NULL
Division	NULL
of	NULL
Pathology	NULL
,	NULL
Centro	NULL
di	NULL
Riferimento	NULL
Oncologico	NULL
,	NULL
IRCCS	NULL
,	NULL
Istituto	NULL
Nazionale	NULL
Tumori	NULL
,	NULL
Aviano	NULL
,	NULL
Italy	NULL
;	NULL
the	NULL
Division	NULL
of	NULL
Internal	NULL
Medicine	NULL
,	NULL
the	NULL
Department	NULL
of	NULL
Medical	NULL
Sciences	NULL
,	NULL
University	NULL
of	NULL
Torino	NULL
at	NULL
Novara	NULL
,	NULL
Novara	NULL
,	NULL
Italy	NULL
;	NULL
the	NULL
Division	NULL
of	NULL
Epidemiology	NULL
,	NULL
Centro	NULL
di	NULL
Riferimento	NULL
Oncologico	NULL
,	NULL
IRCCS	NULL
,	NULL
Istituto	NULL
Nazionale	NULL
Tumori	NULL
,	NULL
Aviano	NULL
,	NULL
Italy	NULL
;	NULL
the	NULL
German	NULL
Collection	NULL
of	NULL
Microorganisms	NULL
&	NULL
Cell	NULL
Cultures	NULL
,	NULL
Human	NULL
and	NULL
Animal	NULL
Cell	NULL
Culture	NULL
Collection	NULL
,	NULL
Braunschweig	NULL
,	NULL
Germany	NULL
;	NULL
the	NULL
Institute	NULL
of	NULL
Hematology	NULL
,	NULL
University	NULL
of	NULL
Perugia	NULL
,	NULL
Italy	NULL
;	NULL
and	NULL
the	NULL
Division	NULL
of	NULL
Oncology	NULL
,	NULL
the	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
College	NULL
of	NULL
Physicians	NULL
and	NULL
Surgeons	NULL
,	NULL
Columbia	NULL
University	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
.	NULL

Submitted	NULL
May	NULL
11	NULL
,	NULL
1998	NULL
;	NULL
accepted	NULL
July	NULL
7	NULL
,	NULL
1998	NULL
.	NULL

Supported	NULL
in	NULL
part	NULL
by	NULL
the	NULL
Associazione	NULL
Italiana	NULL
per	NULL
la	NULL
Ricerca	NULL
sul	NULL
Cancro	NULL
,	NULL
Milan	NULL
,	NULL
Italy	NULL
;	NULL
by	NULL
``	NULL
Fondazione	NULL
CRI	NULL
,	NULL
``	NULL
Torino	NULL
,	NULL
Italy	NULL
;	NULL
and	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grant	NULL
No	NULL
.	NULL

CA-37295	NULL
.	NULL

D.C.	NULL
is	NULL
being	NULL
supported	NULL
by	NULL
a	NULL
fellowship	NULL
from	NULL
Fondazione	NULL
``	NULL
Piera	NULL
Pietro	NULL
e	NULL
Giovanni	NULL
Ferrero	NULL
,	NULL
``	NULL
Alba	NULL
,	NULL
Italy	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Antonino	NULL
Carbone	NULL
,	NULL
MD	NULL
,	NULL
Division	NULL
of	NULL
Pathology	NULL
,	NULL
Centro	NULL
di	NULL
Riferimento	NULL
Oncologico	NULL
,	NULL
IRCCS	NULL
,	NULL
via	NULL
Pedemon-tana	NULL
Occidentale	NULL
,	NULL
Aviano	NULL
I-33081	NULL
,	NULL
Italy	NULL
;	NULL
e-mail	NULL
acarbone	NULL
@	NULL
ets.it	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
adver-tisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/98/9207-0055	NULL
$	NULL
3.00/0	NULL
2220	NULL
heterogeneous	NULL
because	NULL
the	NULL
tumor	NULL
cells	NULL
of	NULL
a	NULL
fraction	NULL
of	NULL
CHD	NULL
display	NULL
the	NULL
BCL-6-/syn-1*	NULL
phenotype	NULL
of	NULL
post-GC	NULL
B-cells	NULL
,	NULL
whereas	NULL
another	NULL
fraction	NULL
of	NULL
CHD	NULL
is	NULL
constituted	NULL
by	NULL
a	NULL
mixture	NULL
of	NULL
tumor	NULL
cells	NULL
reflecting	NULL
the	NULL
GC	NULL
(	NULL
BCL-6+/syn-1~	NULL
)	NULL
or	NULL
post-GC	NULL
(	NULL
BCL-6-/	NULL
syn-1+*	NULL
)	NULL
phenotypes	NULL
.	NULL

BCL-6~/syn-1+*	NULL
tumor	NULL
cells	NULL
of	NULL
CHD	NULL
are	NULL
mostly	NULL
found	NULL
surrounded	NULL
by	NULL
T	NULL
cells	NULL
expressing	NULL
CD40L	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
observation	NULL
that	NULL
CD40	NULL
signaling	NULL
downregulates	NULL
BCL-6	NULL
expression	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
tumor	NULL
cells	NULL
of	NULL
NLPHD	NULL
uniformly	NULL
display	NULL
a	NULL
GC	NULL
B-cell	NULL
phenotype	NULL
,	NULL
whereas	NULL
the	NULL
phenotype	NULL
of	NULL
tumor	NULL
cells	NULL
of	NULL
CHD	NULL
appears	NULL
to	NULL
be	NULL
modulated	NULL
by	NULL
the	NULL
surrounding	NULL
cellular	NULL
background	NULL
,	NULL
particularly	NULL
CD4O0L+	NULL
reactive	NULL
T	NULL
cells	NULL
.	NULL

©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

and	NULL
neoplastic	NULL
cells	NULL
of	NULL
NLPHD	NULL
,	NULL
known	NULL
as	NULL
lymphocytic	NULL
and	NULL
histiocytic	NULL
(	NULL
L	NULL
&	NULL
H	NULL
)	NULL
cells	NULL
,	NULL
differ	NULL
markedly	NULL
in	NULL
terms	NULL
of	NULL
morphol-ogy	NULL
,	NULL
phenotype	NULL
,	NULL
and	NULL
infection	NULL
pattern	NULL
by	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
.	NULL
'	NULL

>	NULL
Whereas	NULL
the	NULL
features	NULL
of	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
are	NULL
relatively	NULL
homogeneous	NULL
,	NULL
RS	NULL
cells	NULL
of	NULL
CHD	NULL
display	NULL
a	NULL
high	NULL
degree	NULL
of	NULL
polymorphism	NULL
which	NULL
remains	NULL
unexplained	NULL
.	NULL
``	NULL

Progression	NULL
of	NULL
normal	NULL
GC	NULL
B	NULL
cells	NULL
to	NULL
later	NULL
stages	NULL
of	NULL
B-cell	NULL
differentiation	NULL
may	NULL
be	NULL
monitored	NULL
by	NULL
following	NULL
the	NULL
expression	NULL
of	NULL
biologic	NULL
markers	NULL
associated	NULL
specifically	NULL
with	NULL
distinct	NULL
subsets	NULL
of	NULL
mature	NULL
B	NULL
cells	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
expression	NULL
of	NULL
BCL-6	NULL
and	NULL
CD138/syndecan-1	NULL
(	NULL
syn-1	NULL
)	NULL
can	NULL
reliably	NULL
discriminate	NULL
between	NULL
GC	NULL
and	NULL
post-GC	NULL
B	NULL
cells	NULL
.	NULL
'	NULL

''	NULL
The	NULL
BCL-6	NULL
protein	NULL
is	NULL
a	NULL
zinc	NULL
finger	NULL
transcriptional	NULL
repressor	NULL
encoded	NULL
by	NULL
the	NULL
BCL-6	NULL
proto-oncogene	NULL
and	NULL
implicated	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
B-cell	NULL
diffuse	NULL
large	NULL
cell	NULL
lymphoma	NULL
(	NULL
B-DLCL	NULL
)	NULL
.	NULL
``	NULL

The	NULL
BCL-6	NULL
protein	NULL
is	NULL
expressed	NULL
by	NULL
GC	NULL
B	NULL
cells	NULL
and	NULL
is	NULL
required	NULL
for	NULL
GC	NULL
formation	NULL
and	NULL
function	NULL
.	NULL
'	NULL

>	NULL
4	NULL
Conversely	NULL
,	NULL
expression	NULL
of	NULL
BCL-6	NULL
is	NULL
negative	NULL
in	NULL
all	NULL
other	NULL
stages	NULL
of	NULL
B-cell	NULL
differentiation	NULL
,	NULL
including	NULL
virgin	NULL
and	NULL
memory	NULL
B	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
plasma	NULL
cells	NULL
.	NULL
``	NULL

Challenging	NULL
of	NULL
GC	NULL
B	NULL
cells	NULL
either	NULL
with	NULL
antigen	NULL
or	NULL
through	NULL
the	NULL
CD40/CD4O0L	NULL
pathway	NULL
causes	NULL
downregulation	NULL
of	NULL
BCL-6	NULL
.	NULL
'	NULL

5	NULL
``	NULL
Similarly	NULL
,	NULL
induction	NULL
of	NULL
the	NULL
EBV-encoded	NULL
latent	NULL
membrane	NULL
protein-1	NULL
(	NULL
LMP-1	NULL
)	NULL
downregulates	NULL
expression	NULL
of	NULL
BCL-6	NULL
in	NULL
B	NULL
cells	NULL
reflecting	NULL
the	NULL
GC	NULL
phenotype	NULL
.	NULL
``	NULL

Syn-1	NULL
is	NULL
a	NULL
proteoglycan	NULL
belonging	NULL
to	NULL
the	NULL
syndecan	NULL
family	NULL
,	NULL
which	NULL
mediates	NULL
cell-to-extracellular	NULL
matrix	NULL
interac-tions	NULL
.	NULL
``	NULL

Among	NULL
mature	NULL
B	NULL
cells	NULL
,	NULL
syn-1	NULL
is	NULL
expressed	NULL
in	NULL
post-GC	NULL
B	NULL
cells	NULL
,	NULL
including	NULL
immunoblasts	NULL
and	NULL
plasma	NULL
cells	NULL
,	NULL
whereas	NULL
it	NULL
is	NULL
absent	NULL
in	NULL
GC	NULL
B	NULL
cells	NULL
.	NULL

!	NULL
``	NULL

Here	NULL
we	NULL
report	NULL
data	NULL
suggesting	NULL
a	NULL
histogenetic	NULL
model	NULL
for	NULL
HD	NULL
development	NULL
.	NULL

Tumor	NULL
cells	NULL
of	NULL
NLPHD	NULL
consistently	NULL
express	NULL
the	NULL
BCL-6+*/syn-1~	NULL
phenotype	NULL
and	NULL
thus	NULL
closely	NULL
reflect	NULL
GC	NULL
B	NULL
cells	NULL
.	NULL

Conversely	NULL
,	NULL
the	NULL
majority	NULL
of	NULL
CHD	NULL
display	NULL
only	NULL
or	NULL
predominantly	NULL
BCL-6~/syn-1	NULL
*	NULL
RS	NULL
cells	NULL
.	NULL

The	NULL
HD	NULL
variants	NULL
identified	NULL
by	NULL
BCL-6	NULL
and	NULL
syn-1	NULL
differ	NULL
in	NULL
terms	NULL
of	NULL
amount	NULL
and	NULL
distribution	NULL
of	NULL
CD4O0L	NULL
*	NULL
reactive	NULL
T	NULL
lymphocytes	NULL
,	NULL
suggesting	NULL
that	NULL
interactions	NULL
between	NULL
CD40	NULL
(	NULL
on	NULL
neoplastic	NULL
cells	NULL
)	NULL
and	NULL
CD4O0L	NULL
(	NULL
on	NULL
reactive	NULL
T	NULL
cells	NULL
)	NULL
is	NULL
a	NULL
crucial	NULL
event	NULL
in	NULL
modulating	NULL
the	NULL
differentiation	NULL
stage	NULL
and	NULL
phenotype	NULL
of	NULL
HD	NULL
.	NULL

Blood	NULL
,	NULL
Vol	NULL
92	NULL
,	NULL
No	NULL
7	NULL
(	NULL
October	NULL
1	NULL
)	NULL
,	NULL
1998	NULL
:	NULL
pp	NULL
2220-2228	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BCL-6	NULL
AND	NULL
Syn-1	NULL
EXPRESSION	NULL
ON	NULL
RS	NULL
CELLS	NULL
OF	NULL
HD	NULL
MATERIALS	NULL
AND	NULL
METHODS	NULL
Samples	NULL
The	NULL
study	NULL
was	NULL
based	NULL
on	NULL
53	NULL
HD	NULL
cases	NULL
for	NULL
which	NULL
frozen	NULL
tissue	NULL
samples	NULL
were	NULL
available	NULL
.	NULL

The	NULL
HD	NULL
panel	NULL
included	NULL
10	NULL
NLPHD	NULL
(	NULL
all	NULL
B-cell	NULL
pheno-type	NULL
)	NULL
and	NULL
43	NULL
CHD	NULL
(	NULL
31	NULL
nodular	NULL
sclerosis	NULL
and	NULL
12	NULL
mixed	NULL
cellularity	NULL
)	NULL
with	NULL
B-cell	NULL
(	NULL
n	NULL
=	NULL
10	NULL
)	NULL
or	NULL
undetermined	NULL
(	NULL
n	NULL
=	NULL
33	NULL
)	NULL
phenotype	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

NLPHD	NULL
was	NULL
diagnosed	NULL
according	NULL
to	NULL
morphologic	NULL
and	NULL
immunophenotypic	NULL
criteria	NULL
.	NULL

The	NULL
CD30+	NULL
,	NULL
CD45~	NULL
,	NULL
CD15+	NULL
,	NULL
EMA~	NULL
(	NULL
epithelial	NULL
membrane	NULL
antigen	NULL
)	NULL
diagnostic	NULL
profile	NULL
was	NULL
required	NULL
for	NULL
the	NULL
diagnosis	NULL
of	NULL
CHD	NULL
.	NULL

!	NULL

The	NULL
Rye	NULL
modification	NULL
of	NULL
the	NULL
Lukes	NULL
and	NULL
Butler	NULL
classification	NULL
was	NULL
used	NULL
to	NULL
classify	NULL
the	NULL
histologic	NULL
subtypes	NULL
of	NULL
CHD	NULL
.	NULL
``	NULL

Frozen	NULL
and/or	NULL
paraffin-embedded	NULL
tissues	NULL
from	NULL
12	NULL
clinical	NULL
samples	NULL
with	NULL
nonneoplastic	NULL
lymphoid	NULL
proliferations	NULL
were	NULL
also	NULL
included	NULL
in	NULL
the	NULL
study	NULL
.	NULL

Immunohistochemistry	NULL
(	NULL
IHC	NULL
)	NULL
IHC	NULL
was	NULL
performed	NULL
with	NULL
the	NULL
alkaline	NULL
phosphatase	NULL
anti-alkaline	NULL
phosphatase	NULL
(	NULL
APAAP	NULL
)	NULL
method	NULL
as	NULL
described	NULL
.	NULL

``	NULL
*	NULL
The	NULL
protocol	NULL
used	NULL
for	NULL
each	NULL
antigen	NULL
tested	NULL
is	NULL
described	NULL
below	NULL
.	NULL

Negative	NULL
control	NULL
experiments	NULL
,	NULL
which	NULL
were	NULL
invariably	NULL
negative	NULL
,	NULL
consisted	NULL
of	NULL
omission	NULL
of	NULL
the	NULL
primary	NULL
antibody	NULL
,	NULL
substitution	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
,	NULL
or	NULL
staining	NULL
with	NULL
irrelevant	NULL
isotype-matched	NULL
mouse	NULL
Ig	NULL
.	NULL

BCL-6	NULL
protein	NULL
.	NULL

The	NULL
BCL-6	NULL
protein	NULL
was	NULL
detected	NULL
by	NULL
the	NULL
PG-B6	NULL
monoclonal	NULL
antibody	NULL
(	NULL
MoAb	NULL
)	NULL
that	NULL
has	NULL
been	NULL
recently	NULL
generated	NULL
in	NULL
the	NULL
laboratory	NULL
of	NULL
one	NULL
of	NULL
the	NULL
investigators	NULL
(	NULL
B.F.	NULL
)	NULL
by	NULL
immunizing	NULL
BALB/c	NULL
mice	NULL
with	NULL
a	NULL
glutathione	NULL
S-transferase-BCL-6	NULL
fusion	NULL
protein	NULL
.	NULL
``	NULL

Immunostaining	NULL
for	NULL
BCL-6	NULL
was	NULL
performed	NULL
on	NULL
frozen	NULL
or	NULL
formalin-fixed	NULL
,	NULL
paraffin-embedded	NULL
sections	NULL
by	NULL
the	NULL
APAAP	NULL
method	NULL
.	NULL
``	NULL

Paraffin-embedded	NULL
tissue	NULL
sections	NULL
were	NULL
pretreated	NULL
in	NULL
a	NULL
microwave	NULL
oven	NULL
(	NULL
Jet	NULL
900	NULL
W	NULL
;	NULL
Philips	NULL
,	NULL
Eindhoven	NULL
,	NULL
The	NULL
Netherlands	NULL
)	NULL
for	NULL
30	NULL
minutes	NULL
at	NULL
250	NULL
W	NULL
in	NULL
EDTA	NULL
solution	NULL
(	NULL
0.05	NULL
mmol	NULL
;	NULL
pH	NULL
8	NULL
)	NULL
.	NULL

Syn-1	NULL
antigen	NULL
.	NULL

-	NULL
Anti-B-B4	NULL
MoAb	NULL
(	NULL
Serotec	NULL
,	NULL
Oxford	NULL
,	NULL
UK	NULL
)	NULL
,	NULL
which	NULL
specifically	NULL
recognizes	NULL
the	NULL
syn-1	NULL
antigen	NULL
,	NULL
``	NULL
``	NULL
was	NULL
applied	NULL
to	NULL
frozen	NULL
tissues	NULL
from	NULL
all	NULL
HD	NULL
cases	NULL
.	NULL

For	NULL
morphologic	NULL
control	NULL
purposes	NULL
,	NULL
the	NULL
MoAb	NULL
was	NULL
also	NULL
applied	NULL
to	NULL
paraffin-embedded	NULL
tissues	NULL
from	NULL
a	NULL
representative	NULL
subset	NULL
of	NULL
HD	NULL
cases	NULL
(	NULL
NLPHD	NULL
,	NULL
4	NULL
cases	NULL
;	NULL
nodular	NULL
sclerosis	NULL
CHD	NULL
,	NULL
15	NULL
cases	NULL
;	NULL
mixed	NULL
cellularity	NULL
CHD	NULL
,	NULL
6	NULL
cases	NULL
)	NULL
.	NULL

Immunohistochemistry	NULL
for	NULL
syn-1	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

CD40	NULL
and	NULL
CD4OL	NULL
.	NULL

-	NULL
Anti-CD40	NULL
MoAb	NULL
89	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
J.	NULL
Bancherau	NULL
,	NULL
Centre	NULL
de	NULL
Recherche	NULL
,	NULL
Schering-Plough	NULL
,	NULL
Dardilly	NULL
,	NULL
France	NULL
)	NULL
was	NULL
applied	NULL
to	NULL
paraffin-embedded	NULL
tissue	NULL
sections	NULL
from	NULL
all	NULL
HD	NULL
cases	NULL
.	NULL

Anti-CD40L	NULL
MoAb	NULL
M90	NULL
(	NULL
Genzyme	NULL
Diagnostic	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
was	NULL
applied	NULL
to	NULL
frozen	NULL
sections	NULL
from	NULL
all	NULL
cases	NULL
included	NULL
in	NULL
the	NULL
study	NULL
because	NULL
of	NULL
its	NULL
lack	NULL
of	NULL
reactivity	NULL
in	NULL
paraffin	NULL
embedded	NULL
tissue	NULL
sections	NULL
.	NULL

Lineage	NULL
assignment	NULL
.	NULL

|	NULL
Further	NULL
immunophenotyping	NULL
and	NULL
lineage	NULL
assignment	NULL
of	NULL
HD	NULL
cases	NULL
was	NULL
performed	NULL
with	NULL
antibodies	NULL
against	NULL
conventional	NULL
B-	NULL
and	NULL
T-cell-associated	NULL
antigens	NULL
,	NULL
as	NULL
reported	NULL
in	NULL
detail	NULL
previously	NULL
.	NULL
``	NULL

Assessment	NULL
of	NULL
BCL-6	NULL
and	NULL
syn-1	NULL
Staining	NULL
in	NULL
HD	NULL
Samples	NULL
At	NULL
least	NULL
100	NULL
neoplastic	NULL
cells	NULL
per	NULL
section	NULL
,	NULL
as	NULL
defined	NULL
by	NULL
histologic	NULL
and	NULL
immunohistologic	NULL
criteria	NULL
(	NULL
CD30	NULL
positivity	NULL
)	NULL
,	NULL
were	NULL
independently	NULL
counted	NULL
by	NULL
two	NULL
of	NULL
us	NULL
(	NULL
A.C.	NULL
,	NULL
A.G.	NULL
)	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
BCL-6*	NULL
or	NULL
syn-1*	NULL
neoplastic	NULL
cells	NULL
was	NULL
assigned	NULL
into	NULL
one	NULL
of	NULL
the	NULL
following	NULL
categories	NULL
:	NULL
0	NULL
,	NULL
<	NULL
10	NULL
%	NULL
,	NULL
10	NULL
%	NULL
to	NULL
25	NULL
%	NULL
,	NULL
25	NULL
%	NULL
to	NULL
50	NULL
%	NULL
,	NULL
50	NULL
%	NULL
to	NULL
75	NULL
%	NULL
,	NULL
and	NULL
>	NULL
75	NULL
%	NULL
.	NULL

Only	NULL
definite	NULL
and	NULL
unambiguous	NULL
staining	NULL
on	NULL
unequivocally	NULL
malignant	NULL
cells	NULL
was	NULL
accepted	NULL
as	NULL
positive	NULL
.	NULL

Two-Color	NULL
Staining	NULL
Multiple	NULL
immunocytochemical	NULL
staining	NULL
was	NULL
performed	NULL
to	NULL
detect	NULL
BCL-6	NULL
plus	NULL
syn-1	NULL
and	NULL
BCL-6	NULL
plus	NULL
LMP-1	NULL
in	NULL
selected	NULL
HD	NULL
samples	NULL
as	NULL
previously	NULL
described	NULL
,	NULL
``	NULL
with	NULL
minor	NULL
modifications	NULL
.	NULL

Briefly	NULL
,	NULL
frozen	NULL
section	NULL
were	NULL
cut	NULL
and	NULL
fixed	NULL
in	NULL
acetone-chloroform	NULL
(	NULL
1:1	NULL
)	NULL
solution	NULL
for	NULL
5	NULL
minutes	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
until	NULL
use	NULL
.	NULL

Slides	NULL
were	NULL
then	NULL
brought	NULL
to	NULL
room	NULL
temperature	NULL
(	NULL
RT	NULL
)	NULL
,	NULL
fixed	NULL
in	NULL
acetone	NULL
for	NULL
5	NULL
minutes	NULL
at	NULL
RT	NULL
,	NULL
air	NULL
dried	NULL
,	NULL
fixed	NULL
in	NULL
buffered	NULL
10	NULL
%	NULL
formalin	NULL
for	NULL
10	NULL
minutes	NULL
at	NULL
RT	NULL
,	NULL
rinsed	NULL
in	NULL
PBS	NULL
pH	NULL
2221	NULL
Table	NULL
1	NULL
.	NULL

Expression	NULL
of	NULL
BCL-6	NULL
,	NULL
Syn-1	NULL
,	NULL
and	NULL
LM	NULL
P-1	NULL
in	NULL
HD	NULL
BCL-6	NULL
Syn-1	NULL
LMP-1	NULL
Case	NULL
Diagnosis	NULL
Phenotype	NULL
(	NULL
%	NULL
)	NULL
*	NULL
(	NULL
%	NULL
)	NULL
*	NULL
(	NULL
%	NULL
)	NULL
*	NULL
1	NULL
NLP	NULL
HD	NULL
B	NULL
>	NULL
75	NULL
0	NULL
0	NULL
2	NULL
NLP	NULL
HD	NULL
B	NULL
>	NULL
75	NULL
0	NULL
0	NULL
3	NULL
NLP	NULL
HD	NULL
B	NULL
>	NULL
75	NULL
0	NULL
0	NULL
4	NULL
NLP	NULL
HD	NULL
B	NULL
>	NULL
75	NULL
0	NULL
0	NULL
5	NULL
NLP	NULL
HD	NULL
B	NULL
>	NULL
75	NULL
0	NULL
0	NULL
6	NULL
NLP	NULL
HD	NULL
B	NULL
>	NULL
75	NULL
0	NULL
0	NULL
7	NULL
NLP	NULL
HD	NULL
B	NULL
>	NULL
75	NULL
0	NULL
0	NULL
8	NULL
NLP	NULL
HD	NULL
B	NULL
>	NULL
75	NULL
0	NULL
0	NULL
9	NULL
NLP	NULL
HD	NULL
B	NULL
>	NULL
75	NULL
0	NULL
0	NULL
10	NULL
NLP	NULL
HD	NULL
B	NULL
>	NULL
75	NULL
0	NULL
0	NULL
11	NULL
MC	NULL
HD	NULL
Undetermined	NULL
<	NULL
10	NULL
<	NULL
10	NULL
10-25	NULL
12	NULL
MC	NULL
HD	NULL
Undetermined	NULL
<	NULL
10	NULL
<	NULL
10	NULL
25-50	NULL
13	NULL
MC	NULL
HD	NULL
Undetermined	NULL
<	NULL
10	NULL
10-25	NULL
0	NULL
14	NULL
MC	NULL
HD	NULL
Undetermined	NULL
<	NULL
10	NULL
10-25	NULL
25-50	NULL
15	NULL
MC	NULL
HD	NULL
Undetermined	NULL
0	NULL
<	NULL
10	NULL
<	NULL
10	NULL
16	NULL
MC	NULL
HD	NULL
Undetermined	NULL
0	NULL
25-50	NULL
0	NULL
17	NULL
MC	NULL
HD	NULL
Undetermined	NULL
0	NULL
25-50	NULL
0	NULL
18	NULL
MC	NULL
HD	NULL
Undetermined	NULL
0	NULL
25-50	NULL
50-75	NULL
19	NULL
MC	NULL
HD	NULL
Undetermined	NULL
0	NULL
25-50	NULL
10-25	NULL
20	NULL
MC	NULL
HD	NULL
Undetermined	NULL
0	NULL
50-75	NULL
0	NULL
21	NULL
MC	NULL
HD	NULL
B	NULL
0	NULL
10-25	NULL
50-75	NULL
22	NULL
MC	NULL
HD	NULL
B	NULL
0	NULL
>	NULL
75	NULL
0	NULL
23	NULL
NS	NULL
HD	NULL
Undetermined	NULL
10-25	NULL
25-50	NULL
50-75	NULL
24	NULL
NS	NULL
HD	NULL
Undetermined	NULL
10-25	NULL
50-75	NULL
0	NULL
25	NULL
NS	NULL
HD	NULL
Undetermined	NULL
10-25	NULL
50-75	NULL
0	NULL
26	NULL
NS	NULL
HD	NULL
Undetermined	NULL
10-25	NULL
50-75	NULL
0	NULL
27	NULL
NS	NULL
HD	NULL
Undetermined	NULL
<	NULL
10	NULL
10-25	NULL
0	NULL
28	NULL
NS	NULL
HD	NULL
Undetermined	NULL
<	NULL
10	NULL
25-50	NULL
0	NULL
29	NULL
NS	NULL
HD	NULL
Undetermined	NULL
<	NULL
10	NULL
25-50	NULL
0	NULL
30	NULL
NS	NULL
HD	NULL
Undetermined	NULL
<	NULL
10	NULL
25-50	NULL
0	NULL
31	NULL
NS	NULL
HD	NULL
Undetermined	NULL
<	NULL
10	NULL
50-75	NULL
0	NULL
32	NULL
NS	NULL
HD	NULL
Undetermined	NULL
<	NULL
10	NULL
50-75	NULL
0	NULL
33	NULL
NS	NULL
HD	NULL
Undetermined	NULL
<	NULL
10	NULL
50-75	NULL
0	NULL
34	NULL
NS	NULL
HD	NULL
Undetermined	NULL
0	NULL
<	NULL
10	NULL
0	NULL
35	NULL
NS	NULL
HD	NULL
Undetermined	NULL
0	NULL
10-25	NULL
0	NULL
36	NULL
NS	NULL
HD	NULL
Undetermined	NULL
0	NULL
10-25	NULL
0	NULL
37	NULL
NS	NULL
HD	NULL
Undetermined	NULL
0	NULL
10-25	NULL
0	NULL
38	NULL
NS	NULL
HD	NULL
Undetermined	NULL
0	NULL
10-25	NULL
50-75	NULL
39	NULL
NS	NULL
HD	NULL
Undetermined	NULL
0	NULL
25-50	NULL
0	NULL
40	NULL
NS	NULL
HD	NULL
Undetermined	NULL
0	NULL
25-50	NULL
0	NULL
41	NULL
NS	NULL
HD	NULL
Undetermined	NULL
0	NULL
25-50	NULL
0	NULL
42	NULL
NS	NULL
HD	NULL
Undetermined	NULL
0	NULL
50-75	NULL
0	NULL
43	NULL
NS	NULL
HD	NULL
Undetermined	NULL
0	NULL
50-75	NULL
0	NULL
44	NULL
NS	NULL
HD	NULL
Undetermined	NULL
0	NULL
50-75	NULL
0	NULL
45	NULL
NS	NULL
HD	NULL
Undetermined	NULL
0	NULL
>	NULL
75	NULL
0	NULL
46	NULL
NS	NULL
HD	NULL
B	NULL
<	NULL
10	NULL
<	NULL
10	NULL
0	NULL
47	NULL
NS	NULL
HD	NULL
B	NULL
<	NULL
10	NULL
50-75	NULL
0	NULL
48	NULL
NS	NULL
HD	NULL
B	NULL
<	NULL
10	NULL
>	NULL
75	NULL
0	NULL
49	NULL
NS	NULL
HD	NULL
B	NULL
0	NULL
10-25	NULL
0	NULL
50	NULL
NS	NULL
HD	NULL
B	NULL
0	NULL
10-25	NULL
0	NULL
51	NULL
NS	NULL
HD	NULL
B	NULL
0	NULL
10-25	NULL
0	NULL
52	NULL
NS	NULL
HD	NULL
B	NULL
0	NULL
50-75	NULL
0	NULL
53	NULL
NS	NULL
HD	NULL
B	NULL
0	NULL
50-75	NULL
0	NULL
RS	NULL
cells	NULL
and	NULL
variants	NULL
of	NULL
all	NULL
HD	NULL
cases	NULL
expressed	NULL
CD40	NULL
antigen	NULL
in	NULL
percentages	NULL
ranging	NULL
from	NULL
50	NULL
%	NULL
to	NULL
75	NULL
%	NULL
.	NULL

Abbreviations	NULL
:	NULL
MC	NULL
,	NULL
mixed	NULL
cellularity	NULL
;	NULL
NS	NULL
,	NULL
nodular	NULL
sclerosis	NULL
.	NULL

*The	NULL
percentage	NULL
of	NULL
BCL-6	NULL
,	NULL
syn-1	NULL
,	NULL
and	NULL
LMP-1	NULL
positive	NULL
neoplastic	NULL
cells	NULL
was	NULL
assigned	NULL
to	NULL
one	NULL
of	NULL
the	NULL
following	NULL
categories	NULL
:	NULL
0	NULL
,	NULL
<	NULL
10	NULL
%	NULL
,	NULL
10	NULL
%	NULL
to	NULL
25	NULL
%	NULL
,	NULL
25	NULL
%	NULL
to	NULL
50	NULL
%	NULL
,	NULL
50	NULL
%	NULL
to	NULL
75	NULL
%	NULL
,	NULL
and	NULL
>	NULL
75	NULL
%	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2222	NULL
7.4	NULL
,	NULL
preincubated	NULL
with	NULL
normal	NULL
rabbit	NULL
serum	NULL
(	NULL
Dakopatts	NULL
A/S	NULL
,	NULL
Glostrup	NULL
,	NULL
Denmark	NULL
)	NULL
for	NULL
5	NULL
minutes	NULL
at	NULL
RT	NULL
,	NULL
and	NULL
incubated	NULL
with	NULL
MoAb	NULL
BCL-6	NULL
(	NULL
undiluted	NULL
,	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
3	NULL
%	NULL
normal	NULL
human	NULL
serum	NULL
)	NULL
for	NULL
1	NULL
hour	NULL
at	NULL
RT	NULL
.	NULL

After	NULL
washing	NULL
in	NULL
0.05	NULL
mol/L	NULL
Tris-buffered	NULL
saline	NULL
(	NULL
TBS	NULL
)	NULL
pH	NULL
7.5	NULL
,	NULL
they	NULL
were	NULL
fixed	NULL
in	NULL
cold	NULL
methanol	NULL
at	NULL
-20°C	NULL
for	NULL
10	NULL
minutes	NULL
and	NULL
then	NULL
immunostained	NULL
by	NULL
the	NULL
APAAP	NULL
method	NULL
``	NULL
using	NULL
naphthol	NULL
AS-MX	NULL
phosphate	NULL
along	NULL
with	NULL
fast	NULL
blue	NULL
BB	NULL
salt	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
for	NULL
the	NULL
development	NULL
of	NULL
alkaline	NULL
phosphatase	NULL
.	NULL

Subsequently	NULL
,	NULL
sections	NULL
were	NULL
treated	NULL
twice	NULL
for	NULL
5	NULL
minutes	NULL
in	NULL
citrate	NULL
buffer	NULL
(	NULL
pH	NULL
6	NULL
)	NULL
in	NULL
a	NULL
microwave	NULL
oven	NULL
to	NULL
denature	NULL
bound	NULL
antibody	NULL
molecules	NULL
and	NULL
to	NULL
inacti-vate	NULL
alkaline	NULL
phosphatase	NULL
present	NULL
in	NULL
the	NULL
APAAP	NULL
complex	NULL
.	NULL

Finally	NULL
,	NULL
sections	NULL
were	NULL
incubated	NULL
overnight	NULL
at	NULL
4°C	NULL
with	NULL
anti-syn-1	NULL
MoAb	NULL
or	NULL
anti-LMP-1	NULL
MoAb	NULL
and	NULL
immunostained	NULL
by	NULL
the	NULL
APAAP	NULL
method	NULL
using	NULL
naphthol	NULL
AS-MX	NULL
phosphate	NULL
along	NULL
with	NULL
fast	NULL
red	NULL
TR	NULL
salt	NULL
(	NULL
Sigma	NULL
)	NULL
for	NULL
the	NULL
development	NULL
of	NULL
alkaline	NULL
phosphatase	NULL
.	NULL

Multiple	NULL
immunocytochemical	NULL
staining	NULL
was	NULL
also	NULL
performed	NULL
to	NULL
detect	NULL
CD40L	NULL
plus	NULL
BCL-6	NULL
and	NULL
CD4O0L	NULL
plus	NULL
syn-1	NULL
in	NULL
selected	NULL
HD	NULL
samples	NULL
.	NULL

Double-immunostaining	NULL
assays	NULL
were	NULL
performed	NULL
on	NULL
frozen	NULL
sections	NULL
using	NULL
CD4OL	NULL
as	NULL
first	NULL
antibody	NULL
.	NULL

These	NULL
experiments	NULL
were	NULL
performed	NULL
following	NULL
the	NULL
above-described	NULL
method	NULL
with	NULL
the	NULL
exception	NULL
that	NULL
the	NULL
CD40L	NULL
MoAb	NULL
was	NULL
applied	NULL
after	NULL
the	NULL
fixation	NULL
in	NULL
methanol	NULL
.	NULL

To	NULL
define	NULL
the	NULL
relative	NULL
abundance	NULL
of	NULL
CD40L+*	NULL
lymphocytes	NULL
in	NULL
the	NULL
reactive	NULL
background	NULL
of	NULL
HD	NULL
,	NULL
a	NULL
semi-quantitative	NULL
analysis	NULL
was	NULL
per-formed	NULL
.	NULL

In	NULL
each	NULL
case	NULL
analyzed	NULL
,	NULL
the	NULL
number	NULL
of	NULL
CD40L	NULL
*	NULL
lymphocytes	NULL
directly	NULL
surrounding	NULL
(	NULL
ie	NULL
,	NULL
rosetting	NULL
)	NULL
each	NULL
RS	NULL
cell	NULL
was	NULL
calculated	NULL
on	NULL
a	NULL
total	NULL
of	NULL
100	NULL
to	NULL
200	NULL
RS	NULL
cells	NULL
counted	NULL
.	NULL

Analysis	NULL
of	NULL
Viral	NULL
Infection	NULL
All	NULL
HD	NULL
samples	NULL
included	NULL
in	NULL
this	NULL
study	NULL
were	NULL
subjected	NULL
to	NULL
determination	NULL
of	NULL
tumor	NULL
infection	NULL
by	NULL
EBV	NULL
.	NULL

EBER	NULL
in	NULL
situ	NULL
hybridization	NULL
(	NULL
ISH	NULL
)	NULL
studies	NULL
were	NULL
performed	NULL
on	NULL
HD	NULL
samples	NULL
to	NULL
identify	NULL
the	NULL
nature	NULL
and	NULL
distribution	NULL
of	NULL
EBV-infected	NULL
cells	NULL
.	NULL
``	NULL

In	NULL
all	NULL
the	NULL
samples	NULL
,	NULL
immunostaining	NULL
for	NULL
LMP-1	NULL
was	NULL
performed	NULL
with	NULL
an	NULL
LMP-1	NULL
specific	NULL
antibody	NULL
(	NULL
Dakopatts	NULL
A/S	NULL
)	NULL
on	NULL
Bouin	NULL
or	NULL
formalin-fixed	NULL
paraffin-embedded	NULL
tissue	NULL
sections	NULL
,	NULL
as	NULL
described	NULL
above	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
LMP-1*	NULL
neoplastic	NULL
cells	NULL
was	NULL
assigned	NULL
to	NULL
one	NULL
of	NULL
the	NULL
following	NULL
categories	NULL
:	NULL
0	NULL
,	NULL
<	NULL
10	NULL
%	NULL
,	NULL
10	NULL
%	NULL
to	NULL
25	NULL
%	NULL
,	NULL
25	NULL
%	NULL
to	NULL
50	NULL
%	NULL
,	NULL
50	NULL
%	NULL
to	NULL
75	NULL
%	NULL
,	NULL
and	NULL
>	NULL
75	NULL
%	NULL
.	NULL

Cell	NULL
Lines	NULL
The	NULL
characteristics	NULL
of	NULL
the	NULL
human	NULL
CHD	NULL
cell	NULL
lines	NULL
L-428	NULL
,	NULL
KM-H2	NULL
,	NULL
SUP-HD1	NULL
,	NULL
SBH-1	NULL
,	NULL
CO	NULL
,	NULL
HD-MY-Z	NULL
,	NULL
HDLM-2	NULL
,	NULL
and	NULL
L-540	NULL
were	NULL
described	NULL
in	NULL
detail	NULL
previously	NULL
.	NULL

?	NULL
``	NULL

CHD-derived	NULL
cell	NULL
lines	NULL
were	NULL
obtained	NULL
through	NULL
the	NULL
German	NULL
Collection	NULL
of	NULL
Microorganisms	NULL
and	NULL
Cell	NULL
Cultures	NULL
(	NULL
Braunschweig	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Cytospin	NULL
preparations	NULL
of	NULL
HD-derived	NULL
cell	NULL
lines	NULL
were	NULL
fixed	NULL
in	NULL
acetone-chloroform	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
10	NULL
minutes	NULL
and	NULL
immunostained	NULL
with	NULL
BCL-6	NULL
and	NULL
anti-B-B4	NULL
MoAbs	NULL
by	NULL
the	NULL
APAAP	NULL
method	NULL
.	NULL
``	NULL

Genetic	NULL
Studies	NULL
of	NULL
BCL-6	NULL
The	NULL
presence	NULL
of	NULL
mutations	NULL
of	NULL
BCL-6	NULL
5	NULL
'	NULL
noncoding	NULL
regions	NULL
was	NULL
tested	NULL
by	NULL
two	NULL
independent	NULL
methods	NULL
,	NULL
including	NULL
polymerase	NULL
chain	NULL
reaction-single	NULL
strand	NULL
conformation	NULL
polymorphism	NULL
(	NULL
PCR-SSCP	NULL
)	NULL
and	NULL
DNA	NULL
CARBONE	NULL
ET	NULL
AL	NULL
direct	NULL
sequencing	NULL
.	NULL

PCR-SSCP	NULL
analysis	NULL
of	NULL
BCL-6	NULL
5°	NULL
noncoding	NULL
regions	NULL
was	NULL
performed	NULL
on	NULL
three	NULL
partially	NULL
overlapping	NULL
PCR	NULL
fragments	NULL
(	NULL
E1.10	NULL
,	NULL
E1.11	NULL
,	NULL
E1.12	NULL
)	NULL
spanning	NULL
739	NULL
bp	NULL
.	NULL

This	NULL
739-bp	NULL
DNA	NULL
fragment	NULL
is	NULL
located	NULL
downstream	NULL
of	NULL
the	NULL
first	NULL
BCL-6	NULL
noncoding	NULL
exon	NULL
and	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
harbor	NULL
greater	NULL
than	NULL
95	NULL
%	NULL
of	NULL
BCL-6	NULL
5	NULL
'	NULL
mutations	NULL
detected	NULL
in	NULL
B-cell	NULL
non-Hodgkin	NULL
's	NULL
lymphomas.3	NULL
%	NULL
'	NULL
DNA	NULL
direct	NULL
sequencing	NULL
was	NULL
performed	NULL
on	NULL
a	NULL
unique	NULL
PCR	NULL
product	NULL
encompassing	NULL
fragments	NULL
E1.10	NULL
,	NULL
E1.11	NULL
,	NULL
and	NULL
E1.12	NULL
using	NULL
a	NULL
commercially	NULL
available	NULL
kit	NULL
(	NULL
Thermosequenase	NULL
;	NULL
Amer-sham	NULL
Life	NULL
Sciences	NULL
,	NULL
Amersham	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

Mutations	NULL
were	NULL
investigated	NULL
in	NULL
CHD	NULL
cell	NULL
lines	NULL
and	NULL
,	NULL
for	NULL
comparative	NULL
purposes	NULL
,	NULL
in	NULL
B-cell	NULL
lymphomas	NULL
known	NULL
to	NULL
derive	NULL
from	NULL
the	NULL
GC	NULL
,	NULL
including	NULL
102	NULL
cases	NULL
of	NULL
B-DLCL	NULL
and	NULL
20	NULL
cases	NULL
of	NULL
follicular	NULL
lymphoma	NULL
(	NULL
FL	NULL
)	NULL
.	NULL

The	NULL
gross	NULL
configuration	NULL
of	NULL
BCL-6	NULL
alleles	NULL
was	NULL
explored	NULL
by	NULL
Southern	NULL
blot	NULL
hybridization	NULL
using	NULL
probes	NULL
that	NULL
recognize	NULL
the	NULL
cluster	NULL
of	NULL
BCL-6	NULL
rearrangements	NULL
detected	NULL
in	NULL
B-cell	NULL
lymphoma	NULL
.	NULL
``	NULL

Quantitative	NULL
analysis	NULL
of	NULL
the	NULL
hybridization	NULL
signal	NULL
was	NULL
performed	NULL
using	NULL
a	NULL
Molecular	NULL
Imager	NULL
System	NULL
(	NULL
Biorad	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Statistical	NULL
Methods	NULL
Difference	NULL
in	NULL
rosetting	NULL
of	NULL
CD4O0L*	NULL
T	NULL
cells	NULL
by	NULL
BCL-6/syn-1	NULL
profile	NULL
was	NULL
assessed	NULL
by	NULL
means	NULL
of	NULL
Wilcoxon	NULL
rank-sum	NULL
test	NULL
for	NULL
unpaired	NULL
data	NULL
and	NULL
analyses	NULL
of	NULL
variance	NULL
.	NULL
``	NULL

RESULTS	NULL
Expression	NULL
Profile	NULL
of	NULL
BCL-6	NULL
,	NULL
syn-1	NULL
,	NULL
and	NULL
CD4OL	NULL
in	NULL
Nonneoplastic	NULL
Lymph	NULL
Nodes	NULL
We	NULL
first	NULL
assessed	NULL
the	NULL
expression	NULL
pattern	NULL
of	NULL
BCL-6	NULL
,	NULL
syn-1	NULL
,	NULL
and	NULL
CD40L	NULL
in	NULL
nonneoplastic	NULL
lymphoid	NULL
tissues	NULL
.	NULL

The	NULL
GC	NULL
B	NULL
cells	NULL
of	NULL
12/12	NULL
(	NULL
100	NULL
%	NULL
)	NULL
nonneoplastic	NULL
lymph	NULL
nodes	NULL
displayed	NULL
a	NULL
strong	NULL
and	NULL
specific	NULL
reactivity	NULL
for	NULL
BCL-6	NULL
.	NULL

The	NULL
B	NULL
cells	NULL
of	NULL
mantle	NULL
and	NULL
paracortical	NULL
zones	NULL
stained	NULL
negative	NULL
for	NULL
BCL-6	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
a	NULL
subset	NULL
of	NULL
large	NULL
B	NULL
cells	NULL
,	NULL
which	NULL
were	NULL
localized	NULL
around	NULL
the	NULL
follicles	NULL
.	NULL

These	NULL
BCL-6*	NULL
large	NULL
B	NULL
cells	NULL
were	NULL
also	NULL
seen	NULL
at	NULL
the	NULL
margins	NULL
of	NULL
the	NULL
GC	NULL
.	NULL

A	NULL
strong	NULL
staining	NULL
for	NULL
syn-1	NULL
was	NULL
found	NULL
on	NULL
plasma	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
other	NULL
cell	NULL
populations	NULL
.	NULL

Overall	NULL
,	NULL
these	NULL
data	NULL
show	NULL
that	NULL
BCL-6	NULL
and	NULL
syn-1	NULL
map	NULL
to	NULL
lymph	NULL
node	NULL
areas	NULL
that	NULL
are	NULL
populated	NULL
by	NULL
B	NULL
cells	NULL
at	NULL
different	NULL
stages	NULL
of	NULL
differentiation	NULL
.	NULL

In	NULL
particular	NULL
,	NULL
B	NULL
cells	NULL
within	NULL
the	NULL
GC	NULL
are	NULL
BCL-6*/syn-1~	NULL
,	NULL
whereas	NULL
plasma	NULL
cells	NULL
,	NULL
which	NULL
predominate	NULL
in	NULL
interfollicular	NULL
areas	NULL
,	NULL
are	NULL
BCL-6-/syn-1	NULL
+	NULL
.	NULL

Expression	NULL
of	NULL
CD4O0L	NULL
in	NULL
nonneoplastic	NULL
lymph	NULL
nodes	NULL
was	NULL
restricted	NULL
to	NULL
small	NULL
lymphocytes	NULL
.	NULL

These	NULL
cells	NULL
usually	NULL
displayed	NULL
a	NULL
prominent	NULL
dotlike	NULL
or	NULL
punctate	NULL
paranuclear	NULL
staining	NULL
and	NULL
occasionally	NULL
exhibited	NULL
a	NULL
membrane	NULL
staining	NULL
pattern	NULL
.	NULL

In	NULL
the	NULL
mantle	NULL
and	NULL
germinal	NULL
center	NULL
light	NULL
zone	NULL
of	NULL
secondary	NULL
follicles	NULL
,	NULL
CD4OL	NULL
*	NULL
cells	NULL
paralleled	NULL
the	NULL
distribution	NULL
of	NULL
CD4*	NULL
T	NULL
lymphocytes	NULL
.	NULL

Expression	NULL
Profile	NULL
of	NULL
BCL-6	NULL
,	NULL
syn-	NULL
1	NULL
,	NULL
and	NULL
CD40/CD4OL	NULL
in	NULL
NLPHD	NULL
In	NULL
10/10	NULL
(	NULL
100	NULL
%	NULL
)	NULL
cases	NULL
of	NULL
NLPHD	NULL
,	NULL
the	NULL
majority	NULL
of	NULL
neoplastic	NULL
(	NULL
L	NULL
&	NULL
H	NULL
)	NULL
cells	NULL
(	NULL
range	NULL
,	NULL
75	NULL
%	NULL
to	NULL
100	NULL
%	NULL
)	NULL
expressed	NULL
BCL-6	NULL
(	NULL
Table	NULL
1	NULL
Fig	NULL
1	NULL
.	NULL

(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
Frozen	NULL
sections	NULL
from	NULL
nodular	NULL
lymphocyte	NULL
predominance	NULL
HD	NULL
stained	NULL
with	NULL
the	NULL
BCL-6	NULL
MoAb	NULL
(	NULL
A	NULL
)	NULL
and	NULL
the	NULL
syn-1	NULL
MoAb	NULL
(	NULL
B	NULL
)	NULL
.	NULL

L	NULL
&	NULL
H	NULL
cells	NULL
show	NULL
a	NULL
strong	NULL
nuclear	NULL
positivity	NULL
for	NULL
BCL-6	NULL
(	NULL
A	NULL
)	NULL
,	NULL
w	NULL
hereas	NULL
no	NULL
syn-1	NULL
expression	NULL
is	NULL
detectable	NULL
(	NULL
arrows	NULL
)	NULL
.	NULL

Residual	NULL
plasma	NULL
cells	NULL
show	NULL
cytoplasmic	NULL
staining	NULL
for	NULL
syn-1	NULL
MoAb	NULL
(	NULL
B	NULL
)	NULL
.	NULL

(	NULL
C	NULL
and	NULL
D	NULL
)	NULL
Frozen	NULL
sections	NULL
from	NULL
classic	NULL
(	NULL
nodular	NULL
sclerosis	NULL
)	NULL
HD	NULL
stained	NULL
with	NULL
the	NULL
BCL-6	NULL
MoAb	NULL
(	NULL
C	NULL
)	NULL
and	NULL
the	NULL
syn-1	NULL
MoAb	NULL
(	NULL
D	NULL
)	NULL
.	NULL

No	NULL
BCL-6	NULL
expression	NULL
is	NULL
detectable	NULL
;	NULL
a	NULL
BCL-6~	NULL
RS	NULL
cell	NULL
is	NULL
shown	NULL
(	NULL
arrow	NULL
)	NULL
(	NULL
C	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
several	NULL
RS	NULL
cells	NULL
show	NULL
cytoplasmic	NULL
and	NULL
membrane	NULL
staining	NULL
for	NULL
syn-1	NULL
(	NULL
D	NULL
)	NULL
.	NULL

(	NULL
E	NULL
and	NULL
F	NULL
)	NULL
Serial	NULL
frozen	NULL
sections	NULL
from	NULL
a	NULL
case	NULL
of	NULL
classic	NULL
(	NULL
nodular	NULL
sclerosis	NULL
)	NULL
HD	NULL
stained	NULL
with	NULL
the	NULL
BCL-6	NULL
MoAb	NULL
(	NULL
E	NULL
)	NULL
and	NULL
the	NULL
syn-1	NULL
MoAb	NULL
(	NULL
F	NULL
)	NULL
.	NULL

Few	NULL
RS	NULL
cells	NULL
show	NULL
a	NULL
nuclear	NULL
positivity	NULL
for	NULL
BCL-6	NULL
(	NULL
E	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
majority	NULL
of	NULL
RS	NULL
cells	NULL
express	NULL
syn-1	NULL
(	NULL
F	NULL
)	NULL
;	NULL
the	NULL
intensity	NULL
of	NULL
staining	NULL
of	NULL
RS	NULL
cells	NULL
for	NULL
syn-1	NULL
(	NULL
arrows	NULL
)	NULL
is	NULL
lower	NULL
than	NULL
that	NULL
of	NULL
reactive	NULL
plasma	NULL
cells	NULL
in	NULL
the	NULL
background	NULL
(	NULL
asterisk	NULL
)	NULL
.	NULL

(	NULL
G	NULL
and	NULL
H	NULL
)	NULL
Frozen	NULL
sections	NULL
from	NULL
cases	NULL
of	NULL
classic	NULL
(	NULL
nodular	NULL
sclerosis	NULL
)	NULL
HD	NULL
tested	NULL
by	NULL
two-color	NULL
staining	NULL
with	NULL
BCL-6	NULL
MoAb	NULL
and	NULL
syn-1	NULL
MoAb	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

In	NULL
both	NULL
cases	NULL
BCL-6+	NULL
(	NULL
nuclear	NULL
,	NULL
blue	NULL
)	NULL
RS	NULL
cells	NULL
and	NULL
syn-1+*	NULL
(	NULL
cytoplasmic	NULL
and	NULL
membranous	NULL
,	NULL
red	NULL
)	NULL
RS	NULL
cells	NULL
(	NULL
arrow	NULL
s	NULL
)	NULL
are	NULL
present	NULL
.	NULL

Note	NULL
positive	NULL
staining	NULL
of	NULL
bystander	NULL
plasma	NULL
cells	NULL
(	NULL
asterisks	NULL
)	NULL
.	NULL

No	NULL
coexpression	NULL
of	NULL
BCL-6	NULL
protein	NULL
is	NULL
detectable	NULL
in	NULL
the	NULL
syn-1+*	NULL
RS	NULL
cells	NULL
.	NULL

APAAP	NULL
immunostaining	NULL
,	NULL
hematoxylin	NULL
counterstain	NULL
(	NULL
A	NULL
through	NULL
F	NULL
)	NULL
.	NULL

Two-color	NULL
staining	NULL
,	NULL
no	NULL
counterstain	NULL
(	NULL
G	NULL
and	NULL
H	NULL
)	NULL
.	NULL

Original	NULL
magnification	NULL
x	NULL
180	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
,	NULL
x	NULL
250	NULL
(	NULL
C	NULL
through	NULL
G	NULL
)	NULL
,	NULL
x	NULL
400	NULL
(	NULL
H	NULL
)	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BCL-6	NULL
AND	NULL
Syn-1	NULL
EXPRESSION	NULL
ON	NULL
RS	NULL
CELLS	NULL
OF	NULL
HD	NULL
2223	NULL
#	NULL
#	NULL
l.	NULL
‘	NULL
1	NULL
as	NULL
.	NULL

#	NULL
\	NULL
k	NULL
f	NULL
#	NULL
:	NULL
.	NULL

*	NULL
®	NULL
``	NULL
``	NULL
1.4	NULL
5	NULL
E	NULL
]	NULL
3	NULL
£+	NULL
@	NULL
a	NULL
#	NULL
6	NULL
*	NULL
A	NULL
©	NULL
B	NULL
»	NULL
¥	NULL
%	NULL
»	NULL
#	NULL
.	NULL

%	NULL
ee	NULL
;	NULL
-	NULL
.	NULL

w	NULL
.	NULL

t	NULL
¥	NULL
a	NULL
.	NULL

#	NULL
#	NULL
«	NULL
m	NULL
¢	NULL
(	NULL
3	NULL
ﬂ.	NULL
s	NULL
T	NULL
*	NULL
#	NULL
*,8	NULL
,	NULL
°	NULL
#	NULL
.	NULL

_	NULL
f	NULL
#	NULL
a	NULL
#	NULL
»	NULL
e	NULL
.	NULL

:	NULL
‘	NULL
‘	NULL
l	NULL
t	NULL
H.	NULL
#	NULL
i.	NULL
n	NULL
‘	NULL
C	NULL
P	NULL
a	NULL
»	NULL
&	NULL
-	NULL
?	NULL
'	NULL

,	NULL
t	NULL
pe	NULL
F	NULL
a	NULL
*	NULL
%	NULL
e	NULL
Pe	NULL
t*	NULL
»	NULL
hn	NULL
y	NULL
*	NULL
b	NULL
.	NULL
``	NULL

``	NULL
``	NULL
o	NULL
.	NULL

&	NULL
.	NULL

#	NULL
La	NULL
f	NULL
\	NULL
&	NULL
J	NULL
3	NULL
a	NULL
Al	NULL
}	NULL
**	NULL
?	NULL

*	NULL
*	NULL
%	NULL
£	NULL
a	NULL
I	NULL
``	NULL
g	NULL
*	NULL
®	NULL
(	NULL
g	NULL
‘	NULL
.	NULL

®	NULL
1	NULL
:	NULL
*	NULL
%	NULL
c	NULL
``	NULL
A	NULL
*	NULL
4	NULL
D	NULL
*	NULL
'	NULL
%	NULL
``	NULL
t	NULL
%	NULL
i	NULL
ain	NULL
``	NULL
#	NULL
\	NULL
fe	NULL
``	NULL
y*	NULL
»	NULL
#	NULL
0	NULL
6	NULL
``	NULL
W	NULL
4	NULL
b	NULL
vﬁé	NULL
_	NULL
a	NULL
R	NULL
~f	NULL
,	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2224	NULL
and	NULL
Fig	NULL
1A	NULL
)	NULL
.	NULL

Syn-1	NULL
expression	NULL
was	NULL
consistently	NULL
negative	NULL
in	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
of	NULL
all	NULL
NLPHD	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
,	NULL
which	NULL
thus	NULL
could	NULL
be	NULL
ascribed	NULL
to	NULL
the	NULL
BCL-6+/syn-1~	NULL
phenotype	NULL
(	NULL
Fig	NULL
1	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

CD40	NULL
was	NULL
strongly	NULL
expressed	NULL
by	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
of	NULL
100	NULL
%	NULL
NLPHD	NULL
.	NULL

Reactive	NULL
CD4O0L+*	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
tumor	NULL
nodules	NULL
of	NULL
NLPHD	NULL
were	NULL
rare	NULL
and	NULL
distributed	NULL
in	NULL
a	NULL
scattered	NULL
fashion	NULL
.	NULL

Rosetting	NULL
of	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
by	NULL
CD4OL*	NULL
T	NULL
cells	NULL
was	NULL
absent	NULL
in	NULL
all	NULL
fields	NULL
analyzed	NULL
,	NULL
suggesting	NULL
that	NULL
CD4O0/CD40L	NULL
interactions	NULL
between	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
and	NULL
reactive	NULL
T	NULL
lymphocytes	NULL
is	NULL
not	NULL
a	NULL
feature	NULL
of	NULL
NLPHD	NULL
.	NULL

L	NULL
&	NULL
H	NULL
cells	NULL
of	NULL
all	NULL
NLPHD	NULL
scored	NULL
negative	NULL
for	NULL
LMP-1	NULL
,	NULL
consistent	NULL
with	NULL
absence	NULL
of	NULL
infection	NULL
by	NULL
EBV	NULL
.	NULL

Expression	NULL
Profile	NULL
of	NULL
BCL-6	NULL
,	NULL
syn-1	NULL
,	NULL
and	NULL
LMP-1	NULL
in	NULL
CHD	NULL
The	NULL
expression	NULL
pattern	NULL
of	NULL
BCL-6	NULL
in	NULL
CHD	NULL
was	NULL
characterized	NULL
by	NULL
a	NULL
certain	NULL
degree	NULL
of	NULL
heterogeneity	NULL
.	NULL

In	NULL
the	NULL
majority	NULL
of	NULL
CHD	NULL
cases	NULL
(	NULL
25/43	NULL
;	NULL
58	NULL
%	NULL
)	NULL
,	NULL
RS	NULL
cells	NULL
did	NULL
not	NULL
express	NULL
BCL-6	NULL
(	NULL
Table	NULL
1	NULL
and	NULL
Fig	NULL
1C	NULL
)	NULL
.	NULL

A	NULL
fraction	NULL
of	NULL
CHD	NULL
(	NULL
18/43	NULL
;	NULL
42	NULL
%	NULL
)	NULL
displayed	NULL
a	NULL
low	NULL
proportion	NULL
of	NULL
BCL-6*	NULL
RS	NULL
cells	NULL
(	NULL
Fig	NULL
1E	NULL
)	NULL
(	NULL
<	NULL
10	NULL
%	NULL
in	NULL
14/18	NULL
)	NULL
.	NULL

Only	NULL
4/43	NULL
(	NULL
9	NULL
%	NULL
)	NULL
CHD	NULL
contained	NULL
>	NULL
10	NULL
%	NULL
BCL-6+*	NULL
RS	NULL
cells	NULL
.	NULL

A	NULL
positive	NULL
staining	NULL
for	NULL
syn-1	NULL
was	NULL
detected	NULL
in	NULL
all	NULL
CHD	NULL
(	NULL
43/43	NULL
;	NULL
100	NULL
%	NULL
)	NULL
,	NULL
although	NULL
the	NULL
proportion	NULL
of	NULL
syn-1*	NULL
RS	NULL
cells	NULL
and	NULL
the	NULL
intensity	NULL
of	NULL
staining	NULL
was	NULL
variable	NULL
among	NULL
the	NULL
cases	NULL
(	NULL
Table	NULL
1	NULL
and	NULL
Fig	NULL
1D	NULL
and	NULL
F	NULL
)	NULL
.	NULL

In	NULL
cases	NULL
containing	NULL
both	NULL
syn-1	NULL
*	NULL
and	NULL
BCL-6+*	NULL
RS	NULL
cells	NULL
(	NULL
n	NULL
=	NULL
18	NULL
;	NULL
Table	NULL
1	NULL
and	NULL
Fig	NULL
1E	NULL
and	NULL
F	NULL
)	NULL
,	NULL
double-staining	NULL
experiments	NULL
showed	NULL
that	NULL
expression	NULL
of	NULL
these	NULL
two	NULL
antigens	NULL
was	NULL
mutually	NULL
exclusive	NULL
in	NULL
the	NULL
same	NULL
RS	NULL
cell	NULL
(	NULL
Fig	NULL
1G	NULL
and	NULL
H	NULL
)	NULL
.	NULL

Comparison	NULL
of	NULL
BCL-6	NULL
and	NULL
syn-1	NULL
expression	NULL
in	NULL
each	NULL
individual	NULL
CHD	NULL
led	NULL
to	NULL
the	NULL
identification	NULL
of	NULL
two	NULL
major	NULL
phenotypic	NULL
profiles	NULL
of	NULL
the	NULL
disease	NULL
(	NULL
Tables	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

The	NULL
first	NULL
phenotypic	NULL
profile	NULL
associated	NULL
with	NULL
25/43	NULL
(	NULL
58	NULL
%	NULL
)	NULL
CHD	NULL
and	NULL
was	NULL
characterized	NULL
by	NULL
BCL-6~/syn-1*	NULL
RS	NULL
cells	NULL
(	NULL
Fig	NULL
1C	NULL
and	NULL
D	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
BCL-6*/syn-1~	NULL
RS	NULL
cells	NULL
.	NULL

The	NULL
second	NULL
phenotypic	NULL
profile	NULL
associated	NULL
with	NULL
18/43	NULL
(	NULL
42	NULL
%	NULL
)	NULL
CHD	NULL
and	NULL
was	NULL
characterized	NULL
by	NULL
the	NULL
coexistence	NULL
of	NULL
BCL-6~/syn-1*	NULL
and	NULL
BCL-6*/syn-1~	NULL
RS	NULL
cells	NULL
(	NULL
Fig	NULL
1E	NULL
through	NULL
H	NULL
)	NULL
in	NULL
the	NULL
same	NULL
biopsy	NULL
.	NULL

Because	NULL
CHD	NULL
may	NULL
be	NULL
subclassified	NULL
in	NULL
terms	NULL
of	NULL
morphology	NULL
(	NULL
nodular	NULL
sclerosis	NULL
v	NULL
mixed	NULL
cellularity	NULL
)	NULL
and	NULL
expression	NULL
of	NULL
conventional	NULL
lymphoid	NULL
markers	NULL
(	NULL
B-cell	NULL
phenotype	NULL
v	NULL
undetermined	NULL
phenotype	NULL
)	NULL
,	NULL
we	NULL
proceded	NULL
to	NULL
compare	NULL
the	NULL
expression	NULL
of	NULL
BCL-6	NULL
and	NULL
syn-1	NULL
with	NULL
the	NULL
morphologic	NULL
and	NULL
phenotypic	NULL
variant	NULL
of	NULL
CHD	NULL
.	NULL

This	NULL
analysis	NULL
showed	NULL
that	NULL
BCL-6+/syn-1~	NULL
and	NULL
BCL-6-/syn-1*	NULL
RS	NULL
cells	NULL
were	NULL
found	NULL
in	NULL
both	NULL
nodular	NULL
sclerosis	NULL
and	NULL
mixed	NULL
cellularity	NULL
subtypes	NULL
and	NULL
in	NULL
all	NULL
conventional	NULL
phenotypes	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Nine	NULL
of	NULL
43	NULL
CHD	NULL
were	NULL
infected	NULL
by	NULL
EBV	NULL
.	NULL

In	NULL
these	NULL
cases	NULL
,	NULL
variable	NULL
proportions	NULL
(	NULL
5	NULL
%	NULL
to	NULL
75	NULL
%	NULL
)	NULL
of	NULL
RS	NULL
cells	NULL
expressed	NULL
LMP-1	NULL
.	NULL

Table	NULL
2	NULL
.	NULL

Profiles	NULL
of	NULL
BCL-6	NULL
and	NULL
Syn-1	NULL
Expression	NULL
in	NULL
HD	NULL
Categories	NULL
Phenotype*	NULL
Patients	NULL
BCL-6*/syn-1~	NULL
+	NULL
Histology	NULL
{	NULL
n	NULL
=	NULL
)	NULL
BCL-6*/syn-1~	NULL
-	NULL
BCL-6~/syn-1+*	NULL
BCL-6~/syn-1*	NULL
NLPHD	NULL
10	NULL
10	NULL
0	NULL
0	NULL
CHD	NULL
43	NULL
0	NULL
25	NULL
18	NULL
MC	NULL
HD	NULL
12	NULL
0	NULL
8	NULL
4	NULL
NS	NULL
HD	NULL
31	NULL
0	NULL
17	NULL
14	NULL
Abbreviations	NULL
:	NULL
MC	NULL
,	NULL
mixed	NULL
cellularity	NULL
;	NULL
NS	NULL
,	NULL
nodular	NULL
sclerosis	NULL
.	NULL

*None	NULL
of	NULL
the	NULL
HD	NULL
cases	NULL
tested	NULL
displayed	NULL
BCL-6~/syn-1~	NULL
phenotype	NULL
only	NULL
.	NULL

CARBONE	NULL
ET	NULL
AL	NULL
In	NULL
cases	NULL
displaying	NULL
both	NULL
LMP-1*	NULL
and	NULL
BCL-6*	NULL
RS	NULL
cells	NULL
(	NULL
n	NULL
=	NULL
4	NULL
)	NULL
,	NULL
double-staining	NULL
experiments	NULL
ruled	NULL
out	NULL
the	NULL
coexpression	NULL
of	NULL
BCL-6	NULL
and	NULL
LMP-1	NULL
by	NULL
the	NULL
same	NULL
RS	NULL
cell	NULL
.	NULL

Relationship	NULL
Between	NULL
RS	NULL
Cell	NULL
Phenotype	NULL
and	NULL
CD40/CD4OL	NULL
Interactions	NULL
in	NULL
CHD	NULL
In	NULL
all	NULL
CHD	NULL
,	NULL
RS	NULL
cells	NULL
strongly	NULL
expressed	NULL
CD40	NULL
but	NULL
were	NULL
consistently	NULL
negative	NULL
for	NULL
CD4OL	NULL
.	NULL

Conversely	NULL
,	NULL
CD4OL	NULL
was	NULL
expressed	NULL
by	NULL
numerous	NULL
T	NULL
lymphocytes	NULL
present	NULL
in	NULL
the	NULL
reactive	NULL
background	NULL
.	NULL

Single-color	NULL
IHC	NULL
showed	NULL
that	NULL
CD4O0L+*	NULL
T	NULL
cells	NULL
localized	NULL
preferentially	NULL
in	NULL
close	NULL
proximity	NULL
of	NULL
RS	NULL
cells	NULL
,	NULL
a	NULL
phenomenon	NULL
known	NULL
as	NULL
rosetting	NULL
.	NULL

Therefore	NULL
,	NULL
by	NULL
means	NULL
of	NULL
serial	NULL
section	NULL
two-color	NULL
IHC	NULL
,	NULL
we	NULL
explored	NULL
the	NULL
relationship	NULL
between	NULL
CD40L*	NULL
T	NULL
cells	NULL
and	NULL
the	NULL
BCL-6/syn-1	NULL
profile	NULL
of	NULL
RS	NULL
cells	NULL
in	NULL
six	NULL
different	NULL
CHD	NULL
cases	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

These	NULL
data	NULL
showed	NULL
that	NULL
in	NULL
most	NULL
instances	NULL
BCL-6+/syn-1~	NULL
RS	NULL
cells	NULL
did	NULL
not	NULL
display	NULL
rosetting	NULL
by	NULL
CD4O0L+®	NULL
T	NULL
cells	NULL
(	NULL
65	NULL
%	NULL
of	NULL
the	NULL
BCL-6*/	NULL
syn-1~	NULL
RS	NULL
cells	NULL
examined	NULL
)	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
93	NULL
%	NULL
of	NULL
BCL-6~/syn-1*	NULL
RS	NULL
cells	NULL
were	NULL
rosetted	NULL
by	NULL
>	NULL
1	NULL
CD4O0L+*	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

CD4O0L*	NULL
T	NULL
cells	NULL
were	NULL
of	NULL
a	NULL
significantly	NULL
higher	NULL
number	NULL
around	NULL
BCL-6-/syn-1*	NULL
RS	NULL
cells	NULL
(	NULL
mean	NULL
=	NULL
1.39	NULL
;	NULL
median	NULL
=	NULL
1	NULL
)	NULL
than	NULL
around	NULL
BCL-6+/syn-1~	NULL
RS	NULL
cells	NULL
(	NULL
mean	NULL
=	NULL
0.39	NULL
;	NULL
median	NULL
=	NULL
0	NULL
)	NULL
(	NULL
Wilcoxon	NULL
2-sample	NULL
test	NULL
,	NULL
P	NULL
<	NULL
.001	NULL
)	NULL
.	NULL

Analyses	NULL
of	NULL
variance	NULL
showed	NULL
that	NULL
the	NULL
most	NULL
important	NULL
source	NULL
of	NULL
difference	NULL
was	NULL
the	NULL
BCL-6/syn-1	NULL
profile	NULL
(	NULL
F	NULL
value	NULL
=	NULL
345.5	NULL
;	NULL
P	NULL
<	NULL
.001	NULL
)	NULL
,	NULL
and	NULL
not	NULL
specific	NULL
examined	NULL
cases	NULL
(	NULL
F	NULL
value	NULL
=	NULL
0.69	NULL
;	NULL
P	NULL
=	NULL
.63	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
Mutations	NULL
of	NULL
the	NULL
5	NULL
``	NULL
Noncoding	NULL
Regions	NULL
of	NULL
BCL-6	NULL
in	NULL
CHD	NULL
Cell	NULL
Lines	NULL
To	NULL
define	NULL
the	NULL
histogenesis	NULL
of	NULL
BCL-6~/syn-1*	NULL
RS	NULL
cells	NULL
,	NULL
we	NULL
have	NULL
investigated	NULL
CHD	NULL
for	NULL
the	NULL
occurrence	NULL
of	NULL
mutations	NULL
of	NULL
BCL-6	NULL
5	NULL
``	NULL
noncoding	NULL
sequences	NULL
.	NULL

These	NULL
mutations	NULL
are	NULL
regarded	NULL
as	NULL
a	NULL
genetic	NULL
marker	NULL
of	NULL
GC	NULL
derivation	NULL
that	NULL
is	NULL
achieved	NULL
during	NULL
B-cell	NULL
transition	NULL
through	NULL
the	NULL
GC	NULL
and	NULL
is	NULL
subsequently	NULL
retained	NULL
during	NULL
further	NULL
Because	NULL
of	NULL
the	NULL
paucity	NULL
of	NULL
RS	NULL
cells	NULL
in	NULL
CHD	NULL
biopsies	NULL
,	NULL
we	NULL
have	NULL
used	NULL
CHD	NULL
cell	NULL
lines	NULL
representative	NULL
of	NULL
B-cell-derived	NULL
CHD	NULL
(	NULL
KM-H2	NULL
,	NULL
SUP-HD1	NULL
,	NULL
SBH-1	NULL
,	NULL
L-428	NULL
)	NULL
expressing	NULL
the	NULL
BCL-6~/syn-1*	NULL
phenotype	NULL
.	NULL

Mutational	NULL
analysis	NULL
by	NULL
DNA	NULL
direct	NULL
sequencing	NULL
showed	NULL
that	NULL
3	NULL
out	NULL
of	NULL
4	NULL
of	NULL
these	NULL
cell	NULL
lines	NULL
(	NULL
KM-H2	NULL
,	NULL
SUP-HD1	NULL
,	NULL
and	NULL
L-428	NULL
)	NULL
harbored	NULL
BCL-6	NULL
5	NULL
'	NULL
mutations	NULL
clustering	NULL
in	NULL
the	NULL
proximity	NULL
of	NULL
the	NULL
BCL-6	NULL
promoter	NULL
(	NULL
Table	NULL
3	NULL
and	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

The	NULL
frequency	NULL
of	NULL
BCL-6	NULL
mutations	NULL
in	NULL
CHD	NULL
cell	NULL
lines	NULL
(	NULL
Table	NULL
3	NULL
)	NULL
was	NULL
within	NULL
the	NULL
range	NULL
of	NULL
mutation	NULL
rates	NULL
detected	NULL
in	NULL
other	NULL
lymphomas	NULL
known	NULL
to	NULL
derive	NULL
from	NULL
the	NULL
GC	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
our	NULL
analysis	NULL
of	NULL
102	NULL
cases	NULL
of	NULL
B-DLCL	NULL
and	NULL
20	NULL
cases	NULL
of	NULL
FL	NULL
(	NULL
G.G	NULL
.	NULL

,	NULL
D.C.	NULL
,	NULL
A.C.	NULL
,	NULL
unpublished	NULL
observation	NULL
,	NULL
May	NULL
1998	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
the	NULL
spectrum	NULL
of	NULL
BCL-6	NULL
mutations	NULL
observed	NULL
in	NULL
CHD	NULL
cell	NULL
lines	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
B-DLCL	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
a	NULL
predominance	NULL
of	NULL
single-nucleotide	NULL
substitutions	NULL
over	NULL
point	NULL
insertions	NULL
and	NULL
deletions	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
relative	NULL
excess	NULL
of	NULL
transitions	NULL
versus	NULL
transversions	NULL
.	NULL

Mutations	NULL
of	NULL
BCL-6	NULL
5	NULL
'	NULL
noncoding	NULL
regions	NULL
appeared	NULL
to	NULL
be	NULL
specific	NULL
for	NULL
CHD	NULL
cell	NULL
lines	NULL
of	NULL
B-cell	NULL
origin	NULL
,	NULL
because	NULL
the	NULL
CHD	NULL
cell	NULL
lines	NULL
L-540	NULL
,	NULL
HDLM-2	NULL
,	NULL
CO	NULL
,	NULL
and	NULL
HD-MY-Z	NULL
,	NULL
which	NULL
derive	NULL
from	NULL
lineages	NULL
other	NULL
than	NULL
B	NULL
cells	NULL
,	NULL
were	NULL
devoid	NULL
of	NULL
mutations	NULL
.	NULL

DISCUSSION	NULL
The	NULL
aim	NULL
of	NULL
this	NULL
study	NULL
was	NULL
to	NULL
investigate	NULL
the	NULL
histogenesis	NULL
of	NULL
the	NULL
pathologic	NULL
spectrum	NULL
of	NULL
HD	NULL
.	NULL

The	NULL
implications	NULL
suggested	NULL
by	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BCL-6	NULL
AND	NULL
Syn-1	NULL
EXPRESSION	NULL
ON	NULL
RS	NULL
CELLS	NULL
OF	NULL
HD	NULL
``	NULL
4	NULL
C	NULL
D	NULL
2225	NULL
E	NULL
Fig	NULL
2	NULL
.	NULL

(	NULL
A	NULL
through	NULL
E	NULL
)	NULL
Frozen	NULL
sections	NULL
from	NULL
a	NULL
case	NULL
of	NULL
classic	NULL
(	NULL
nodular	NULL
sclerosis	NULL
)	NULL
HD	NULL
tested	NULL
by	NULL
two-color	NULL
staining	NULL
with	NULL
CD4OL	NULL
and	NULL
BCL-6	NULL
MoAbs	NULL
(	NULL
A	NULL
,	NULL
C	NULL
,	NULL
and	NULL
D	NULL
)	NULL
and	NULL
CD4O0L	NULL
and	NULL
syn-1	NULL
MoAbs	NULL
(	NULL
B	NULL
and	NULL
E	NULL
)	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Only	NULL
scattered	NULL
CD4O0L+	NULL
(	NULL
cytoplasmic	NULL
,	NULL
blue	NULL
)	NULL
lymphoid	NULL
cells	NULL
are	NULL
detectable	NULL
in	NULL
the	NULL
proximity	NULL
of	NULL
BCL-6+*	NULL
(	NULL
nuclear	NULL
,	NULL
red	NULL
)	NULL
RS	NULL
cells	NULL
(	NULL
A	NULL
)	NULL
,	NULL
whereas	NULL
expression	NULL
of	NULL
CD4O0L	NULL
(	NULL
cytoplasmic	NULL
,	NULL
blue	NULL
)	NULL
can	NULL
be	NULL
observed	NULL
on	NULL
several	NULL
reactive	NULL
lymphocytes	NULL
that	NULL
surround	NULL
syn-1*	NULL
(	NULL
cytoplasmic	NULL
and	NULL
membranous	NULL
,	NULL
red	NULL
)	NULL
RS	NULL
cells	NULL
(	NULL
B	NULL
)	NULL
.	NULL

(	NULL
A	NULL
,	NULL
inset	NULL
)	NULL
A	NULL
higher	NULL
magnification	NULL
of	NULL
BCL-6+	NULL
RS	NULL
cells	NULL
with	NULL
two	NULL
CD40L+	NULL
lymphoid	NULL
cells	NULL
(	NULL
arrows	NULL
)	NULL
.	NULL

(	NULL
C	NULL
through	NULL
E	NULL
)	NULL
RS	NULL
cells	NULL
of	NULL
classic	NULL
HD	NULL
displaying	NULL
the	NULL
BCL-6+*	NULL
(	NULL
C	NULL
)	NULL
,	NULL
BCL-6~	NULL
(	NULL
D	NULL
)	NULL
,	NULL
and	NULL
syn-1*	NULL
(	NULL
E	NULL
)	NULL
phenotype	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
BCL-6+	NULL
RS	NULL
cell	NULL
does	NULL
not	NULL
display	NULL
close	NULL
association	NULL
with	NULL
CD4O0L+	NULL
T	NULL
cells	NULL
(	NULL
C	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
both	NULL
BCL-6~	NULL
(	NULL
D	NULL
)	NULL
and	NULL
syn-1+*	NULL
(	NULL
E	NULL
)	NULL
RS	NULL
cells	NULL
are	NULL
accom	NULL
panied	NULL
by	NULL
several	NULL
CD40L+	NULL
T	NULL
cells	NULL
.	NULL

Two-color	NULL
staining	NULL
,	NULL
no	NULL
counterstain	NULL
.	NULL

Original	NULL
magnification	NULL
x	NULL
180	NULL
(	NULL
A	NULL
)	NULL
,	NULL
x	NULL
250	NULL
(	NULL
inset	NULL
A	NULL
)	NULL
,	NULL
x	NULL
400	NULL
(	NULL
B	NULL
)	NULL
,	NULL
x	NULL
630	NULL
(	NULL
C	NULL
,	NULL
D	NULL
,	NULL
and	NULL
E	NULL
)	NULL
.	NULL

our	NULL
data	NULL
are	NULL
twofold	NULL
.	NULL

First	NULL
,	NULL
different	NULL
categories	NULL
of	NULL
HD	NULL
with	NULL
B-cell	NULL
or	NULL
undetermined	NULL
phenotype	NULL
correspond	NULL
to	NULL
different	NULL
stages	NULL
of	NULL
B-cell	NULL
maturation	NULL
.	NULL

Second	NULL
,	NULL
the	NULL
maturation	NULL
stage	NULL
of	NULL
the	NULL
HD	NULL
neoplastic	NULL
clone	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
different	NULL
composition	NULL
of	NULL
the	NULL
reactive	NULL
background	NULL
of	NULL
HD	NULL
.	NULL

The	NULL
expression	NULL
profile	NULL
of	NULL
BCL-6	NULL
and	NULL
syn-1	NULL
in	NULL
the	NULL
neoplastic	NULL
cells	NULL
of	NULL
HD	NULL
segregates	NULL
two	NULL
major	NULL
phenotypic	NULL
categories	NULL
of	NULL
the	NULL
disease	NULL
,	NULL
ie	NULL
,	NULL
BCL-6*/syn-1~	NULL
and	NULL
BCL-6-/syn-1*	NULL
.	NULL

In	NULL
normal	NULL
lymphoid	NULL
tissues	NULL
,	NULL
these	NULL
phenotypic	NULL
profiles	NULL
correspond	NULL
to	NULL
GC	NULL
and	NULL
post-GC	NULL
B	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL
'	NULL

''	NULL
``	NULL
The	NULL
BCL-6*/syn-1~	NULL
profile	NULL
associates	NULL
with	NULL
100	NULL
%	NULL
NLPHD	NULL
,	NULL
thus	NULL
corroborating	NULL
the	NULL
notion	NULL
that	NULL
NLPHD	NULL
is	NULL
a	NULL
relatively	NULL
homogenous	NULL
disorder	NULL
closely	NULL
reflecting	NULL
the	NULL
GC	NULL
phenotype	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
.2	NULL
>	NULL
>	NULL
The	NULL
BCL-6-/syn-1*	NULL
profile	NULL
associates	NULL
with	NULL
the	NULL
majority	NULL
of	NULL
CHD	NULL
,	NULL
indicating	NULL
that	NULL
RS	NULL
cells	NULL
are	NULL
frequently	NULL
represented	NULL
by	NULL
post-GC	NULL
B	NULL
cells	NULL
that	NULL
have	NULL
undergone	NULL
preterminal	NULL
differentiation	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
.	NULL

Although	NULL
BCL-6~-/	NULL
syn-1*	NULL
RS	NULL
cells	NULL
no	NULL
longer	NULL
express	NULL
GC-restricted	NULL
phenotypic	NULL
markers	NULL
,	NULL
their	NULL
histogenetic	NULL
derivation	NULL
from	NULL
GC	NULL
cells	NULL
is	NULL
indicated	NULL
by	NULL
the	NULL
association	NULL
with	NULL
molecular	NULL
hallmarks	NULL
of	NULL
GC	NULL
transition	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
this	NULL
and	NULL
previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
RS	NULL
cells	NULL
of	NULL
CHD	NULL
harbor	NULL
mutations	NULL
of	NULL
BCL-6	NULL
and	NULL
Ig	NULL
genes	NULL
,	NULL
which	NULL
are	NULL
regarded	NULL
as	NULL
markers	NULL
of	NULL
B-cell	NULL
transition	NULL
through	NULL
the	NULL
GC.5	NULL
``	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2226	NULL
CARBONE	NULL
ET	NULL
AL	NULL
Table	NULL
3	NULL
.	NULL

Characteristics	NULL
of	NULL
Mutations	NULL
of	NULL
BCL-6	NULL
5°	NULL
Noncoding	NULL
Regions	NULL
in	NULL
CHD	NULL
Cell	NULL
Lines	NULL
Cell	NULL
Line	NULL
Nucleotide	NULL
Substitution*	NULL
Mutation	NULL
Frequencyt	NULL
Mutation	NULL
Status	NULL
(	NULL
x10-	NULL
%	NULL
op	NULL
)	NULL
L-428	NULL
G	NULL
-	NULL
A	NULL
(	NULL
438	NULL
)	NULL
,	NULL
T	NULL
-	NULL
A	NULL
(	NULL
448	NULL
)	NULL
,	NULL
C-	NULL
T	NULL
(	NULL
475	NULL
)	NULL
,	NULL
T	NULL
-	NULL
G	NULL
(	NULL
557	NULL
)	NULL
,	NULL
Heterozygous	NULL
9.47	NULL
T	NULL
-	NULL
C	NULL
(	NULL
602	NULL
)	NULL
,	NULL
T	NULL
-	NULL
C	NULL
(	NULL
646	NULL
)	NULL
,	NULL
A	NULL
-	NULL
G	NULL
(	NULL
657	NULL
)	NULL
,	NULL
A	NULL
-	NULL
C	NULL
(	NULL
693	NULL
)	NULL
,	NULL
T	NULL
-	NULL
C	NULL
(	NULL
840	NULL
)	NULL
,	NULL
C-	NULL
G	NULL
(	NULL
904	NULL
)	NULL
,	NULL
T-	NULL
C	NULL
(	NULL
1042	NULL
)	NULL
,	NULL
A	NULL
-C	NULL
(	NULL
1063	NULL
)	NULL
,	NULL
A	NULL
-G	NULL
(	NULL
1064	NULL
)	NULL
,	NULL
A	NULL
-C	NULL
(	NULL
1071	NULL
)	NULL
sUP-HD1	NULL
G-	NULL
T	NULL
(	NULL
440	NULL
)	NULL
,	NULL
G	NULL
-	NULL
A	NULL
(	NULL
478	NULL
)	NULL
,	NULL
G	NULL
-	NULL
A	NULL
(	NULL
488	NULL
)	NULL
,	NULL
C-	NULL
G	NULL
(	NULL
520	NULL
)	NULL
,	NULL
Homo-/hemizygoust	NULL
29.8	NULL
C-	NULL
A	NULL
(	NULL
522	NULL
)	NULL
,	NULL
C-	NULL
A	NULL
(	NULL
525	NULL
)	NULL
,	NULL
C-	NULL
A	NULL
(	NULL
526	NULL
)	NULL
,	NULL
T-	NULL
G	NULL
(	NULL
557	NULL
)	NULL
,	NULL
A	NULL
-	NULL
G	NULL
(	NULL
643	NULL
)	NULL
,	NULL
G	NULL
-	NULL
A	NULL
(	NULL
648	NULL
)	NULL
,	NULL
G	NULL
-	NULL
A	NULL
(	NULL
758	NULL
)	NULL
,	NULL
C-	NULL
G	NULL
(	NULL
771	NULL
)	NULL
,	NULL
C-	NULL
G	NULL
(	NULL
779	NULL
)	NULL
,	NULL
T	NULL
-	NULL
A	NULL
(	NULL
782	NULL
)	NULL
,	NULL
C-	NULL
G	NULL
(	NULL
788	NULL
)	NULL
,	NULL
T	NULL
-	NULL
C	NULL
(	NULL
792	NULL
)	NULL
,	NULL
AT	NULL
(	NULL
836	NULL
)	NULL
,	NULL
C-	NULL
T	NULL
(	NULL
875	NULL
)	NULL
,	NULL
T-	NULL
G	NULL
(	NULL
908	NULL
)	NULL
,	NULL
T-	NULL
G	NULL
(	NULL
911	NULL
)	NULL
,	NULL
T-	NULL
G	NULL
(	NULL
924	NULL
)	NULL
,	NULL
T	NULL
-	NULL
C	NULL
(	NULL
927	NULL
)	NULL
,	NULL
a	NULL
-	NULL
A	NULL
(	NULL
952	NULL
)	NULL
,	NULL
C-	NULL
G	NULL
(	NULL
959	NULL
)	NULL
,	NULL
G-	NULL
A	NULL
(	NULL
966	NULL
)	NULL
,	NULL
T	NULL
-	NULL
A	NULL
(	NULL
980	NULL
)	NULL
,	NULL
G-	NULL
A	NULL
(	NULL
981	NULL
)	NULL
,	NULL
G	NULL
-	NULL
A	NULL
(	NULL
1002	NULL
)	NULL
,	NULL
A	NULL
-	NULL
T	NULL
(	NULL
1051	NULL
)	NULL
,	NULL
T-	NULL
G	NULL
(	NULL
1104	NULL
)	NULL
KM	NULL
-H2	NULL
a-	NULL
A	NULL
(	NULL
962	NULL
)	NULL
Homo-/hemizygoust	NULL
1.35	NULL
*	NULL
The	NULL
nucleotide	NULL
position	NULL
is	NULL
indicated	NULL
in	NULL
brackets	NULL
.	NULL

A	NULL
,	NULL
deletion	NULL
.	NULL

{	NULL
Frequency	NULL
of	NULL
mutated/tested	NULL
nucleotides	NULL
.	NULL

{	NULL
The	NULL
wild-type	NULL
sequence	NULL
of	NULL
BCL-6	NULL
was	NULL
not	NULL
detectable	NULL
in	NULL
this	NULL
case	NULL
.	NULL

The	NULL
differences	NULL
observed	NULL
in	NULL
BCL-6	NULL
and	NULL
syn-1	NULL
expression	NULL
throughout	NULL
the	NULL
pathologic	NULL
spectrum	NULL
of	NULL
HD	NULL
may	NULL
be	NULL
caused	NULL
by	NULL
differences	NULL
in	NULL
the	NULL
composition	NULL
of	NULL
the	NULL
reactive	NULL
background	NULL
.	NULL

It	NULL
is	NULL
well	NULL
established	NULL
that	NULL
rosetting	NULL
of	NULL
RS	NULL
cells	NULL
by	NULL
activated	NULL
CD4*	NULL
T	NULL
lymphocytes	NULL
is	NULL
mediated	NULL
in	NULL
part	NULL
by	NULL
the	NULL
CD40/CD4OL	NULL
adhesion	NULL
pathway	NULL
and	NULL
that	NULL
signaling	NULL
between	NULL
RS	NULL
cells	NULL
and	NULL
rosetting	NULL
T	NULL
lymphocytes	NULL
actively	NULL
involves	NULL
the	NULL
CD40/CD4OL	NULL
system	NULL
.	NULL

``	NULL
>	NULL
5	NULL
``	NULL
``	NULL
Whereas	NULL
CD40	NULL
is	NULL
consistently	NULL
expressed	NULL
by	NULL
both	NULL
L	NULL
&	NULL
H	NULL
and	NULL
RS	NULL
cells	NULL
,	NULL
the	NULL
abundance	NULL
and	NULL
distribution	NULL
of	NULL
CD4O0L	NULL
*	NULL
T	NULL
lymphocytes	NULL
varies	NULL
markedly	NULL
in	NULL
different	NULL
HD	NULL
categories	NULL
``	NULL
(	NULL
and	NULL
this	NULL
study	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
indicate	NULL
that	NULL
CD40/CDA4O0L	NULL
signaling	NULL
between	NULL
neoplastic	NULL
and	NULL
reactive	NULL
cells	NULL
is	NULL
a	NULL
prominent	NULL
feature	NULL
of	NULL
CHD	NULL
,	NULL
but	NULL
not	NULL
of	NULL
NLPHD	NULL
,	NULL
and	NULL
that	NULL
it	NULL
preferentially	NULL
clusters	NULL
with	NULL
RS	NULL
cells	NULL
displaying	NULL
the	NULL
BCL-6~-/syn-1*	NULL
phenotype	NULL
.	NULL

Fig	NULL
3	NULL
.	NULL

Mutational	NULL
analysis	NULL
of	NULL
the	NULL
5°	NULL
noncoding	NULL
regions	NULL
of	NULL
BCL-6	NULL
in	NULL
HD	NULL
cell	NULL
lines	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Analysis	NULL
by	NULL
PCR-SSCP	NULL
.	NULL

Representative	NULL
results	NULL
obtained	NULL
for	NULL
PCR	NULL
products	NULL
E1.11	NULL
and	NULL
E1.12	NULL
are	NULL
show	NULL
n.	NULL
HD	NULL
cell	NULL
lines	NULL
are	NULL
indicated	NULL
at	NULL
the	NULL
top	NULL
of	NULL
each	NULL
lane	NULL
by	NULL
their	NULL
conventional	NULL
denomination	NULL
.	NULL

A	NULL
positive	NULL
control	NULL
(	NULL
POS	NULL
)	NULL
,	NULL
represented	NULL
by	NULL
a	NULL
tumor	NULL
sample	NULL
known	NULL
to	NULL
harbor	NULL
BCL-6	NULL
5°	NULL
mutations	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
normal	NULL
(	NULL
N	NULL
)	NULL
sample	NULL
,	NULL
represented	NULL
by	NULL
a	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
,	NULL
are	NULL
also	NULL
included	NULL
for	NULL
each	NULL
PCR-SSCP	NULL
fragment	NULL
show	NULL
n.	NULL
Samples	NULL
were	NULL
scored	NULL
positive	NULL
when	NULL
their	NULL
migration	NULL
pattern	NULL
differed	NULL
from	NULL
the	NULL
normal	NULL
control	NULL
(	NULL
N	NULL
)	NULL
and	NULL
the	NULL
migration	NULL
abnormalities	NULL
could	NULL
not	NULL
be	NULL
ascribed	NULL
to	NULL
population	NULL
poly-morphisms	NULL
.	NULL

Among	NULL
the	NULL
samples	NULL
show	NULL
n	NULL
,	NULL
cell	NULL
lines	NULL
scored	NULL
as	NULL
positive	NULL
included	NULL
L-428	NULL
for	NULL
PCR	NULL
products	NULL
E1.11	NULL
and	NULL
1.12	NULL
and	NULL
KM-H2	NULL
for	NULL
PCR	NULL
product	NULL
E1.12	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Analy-	NULL
KM-H2	NULL
N	NULL
N	NULL
L428	NULL
sis	NULL
by	NULL
DNA	NULL
direct	NULL
sequencing	NULL
.	NULL

The	NULL
nucleotide	NULL
sequence	NULL
of	NULL
each	NULL
T	NULL
C	NULL
GA	NULL
T	NULL
C	NULL
G	NULL
A	NULL
T	NULL
C	NULL
G	NULL
A	NULL
T	NULL
CG	NULL
aA	NULL
case	NULL
shown	NULL
in	NULL
the	NULL
figure	NULL
is	NULL
«	NULL
®	NULL
_	NULL
``	NULL
ugs	NULL
*	NULL
aime	NULL
~	NULL
am	NULL
matched	NULL
to	NULL
the	NULL
sequence	NULL
of	NULL
a	NULL
*e	NULL
-	NULL
e	NULL
.	NULL

'are	NULL
..	NULL
normal	NULL
control	NULL
(	NULL
N	NULL
)	NULL
displaying	NULL
fa	NULL
‘	NULL
-	NULL
=	NULL
.	NULL

.	NULL

germline	NULL
BCL-6	NULL
alleles	NULL
.	NULL

The	NULL
posi-	NULL
«	NULL
te	NULL
``	NULL
*	NULL
cu	NULL
;	NULL
'	NULL
1063	NULL
tion	NULL
of	NULL
mutations	NULL
is	NULL
indicated	NULL
G	NULL
-	NULL
>	NULL
A	NULL
962	NULL
>	NULL
~4	NULL
.	NULL

8	NULL
e	NULL
«	NULL
--	NULL
-	NULL
a	NULL
-	NULL
>	NULL
(	NULL
arrow	NULL
)	NULL
by	NULL
the	NULL
nucleotide	NULL
num-	NULL
``	NULL
``	NULL
€	NULL
1064	NULL
-	NULL
>	NULL
ber	NULL
of	NULL
the	NULL
corresponding	NULL
BCL-6	NULL
—	NULL
‘	NULL
j	NULL
|	NULL
germline	NULL
sequence	NULL
(	NULL
the	NULL
first	NULL
nu-i	NULL
1071	NULL
cleotide	NULL
of	NULL
the	NULL
BCL-6	NULL
cDNA	NULL
was	NULL
®	NULL
‘	NULL
Is	NULL
_	NULL
<	NULL
€	NULL
--	NULL
-A	NULL
-	NULL
>	NULL
C	NULL
arbitrarily	NULL
chosen	NULL
as	NULL
position	NULL
+1	NULL
)	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

BCL-6	NULL
AND	NULL
Syn-1	NULL
EXPRESSION	NULL
ON	NULL
RS	NULL
CELLS	NULL
OF	NULL
HD	NULL
pre-GC	NULL
B-CELLS	NULL
BCL-6/syn-1~	NULL
GC	NULL
B-CELLS	NULL
PLASMACELLS	NULL
BCL-6/syn-1*	NULL
Ons	NULL
-	NULL
.	NULL

|	NULL
©	NULL
©	NULL
@	NULL
|	NULL
--	NULL
@	NULL
@	NULL
c*	NULL
ce0e	NULL
NLPHD	NULL
BCL-6*4/syn-1-	NULL
CD40/CD40L	NULL
INTERACTION	NULL
)	NULL
/CHD	NULL
BCL-6*/syn-1-	NULL
__	NULL
BCL-6-/syn-1*	NULL
Fig	NULL
4	NULL
.	NULL

A	NULL
model	NULL
of	NULL
HD	NULL
histogenesis	NULL
.	NULL

The	NULL
proposed	NULL
model	NULL
is	NULL
based	NULL
on	NULL
the	NULL
expression	NULL
pattern	NULL
of	NULL
BCL-6	NULL
and	NULL
syn-1	NULL
throughout	NULL
physiologic	NULL
B-cell	NULL
differentiation	NULL
.	NULL

B	NULL
cells	NULL
within	NULL
the	NULL
GC	NULL
display	NULL
the	NULL
BCL-6+*/syn-1~	NULL
phenotype	NULL
,	NULL
whereas	NULL
B	NULL
cells	NULL
that	NULL
have	NULL
exited	NULL
the	NULL
GC	NULL
and	NULL
have	NULL
undergone	NULL
further	NULL
maturation	NULL
toward	NULL
the	NULL
plasma	NULL
cell	NULL
stage	NULL
exhibit	NULL
the	NULL
BCL-G6-/syn-1*	NULL
phenotype	NULL
.	NULL

On	NULL
this	NULL
basis	NULL
,	NULL
neoplastic	NULL
cells	NULL
of	NULL
NLPHD	NULL
consistently	NULL
express	NULL
the	NULL
BCL-6+/syn-1~	NULL
phenotype	NULL
and	NULL
thus	NULL
closely	NULL
reflect	NULL
the	NULL
GC	NULL
phenotype	NULL
.	NULL

Conversely	NULL
,	NULL
RS	NULL
cells	NULL
of	NULL
CHD	NULL
may	NULL
express	NULL
either	NULL
the	NULL
BCL-6+/syn-1~	NULL
phenotype	NULL
or	NULL
the	NULL
BCL-6-/syn-1+*	NULL
phenotype	NULL
,	NULL
consistent	NULL
with	NULL
further	NULL
maturation	NULL
tow	NULL
ard	NULL
the	NULL
late	NULL
stages	NULL
of	NULL
B-cell	NULL
differentiation	NULL
.	NULL

Most	NULL
CHD	NULL
cases	NULL
display	NULL
only	NULL
BCL-6-/syn-1+*	NULL
RS	NULL
cells	NULL
,	NULL
whereas	NULL
a	NULL
fraction	NULL
of	NULL
CHD	NULL
displays	NULL
a	NULL
mixture	NULL
of	NULL
BCL-6+/	NULL
syn-1~	NULL
and	NULL
BCL-6-/syn-1+*	NULL
RS	NULL
cells	NULL
,	NULL
suggesting	NULL
heterogeneity	NULL
in	NULL
the	NULL
differentiation	NULL
stage	NULL
of	NULL
the	NULL
neoplastic	NULL
clone	NULL
.	NULL

The	NULL
CD40	NULL
molecule	NULL
is	NULL
expressed	NULL
on	NULL
neoplastic	NULL
cells	NULL
of	NULL
both	NULL
NLPHD	NULL
and	NULL
HD	NULL
,	NULL
whereas	NULL
expression	NULL
of	NULL
CD40L	NULL
by	NULL
reactive	NULL
T	NULL
cells	NULL
is	NULL
restricted	NULL
to	NULL
the	NULL
case	NULL
of	NULL
CHD	NULL
and	NULL
is	NULL
consistently	NULL
absent	NULL
in	NULL
NLPHD	NULL
.	NULL

In	NULL
CHD	NULL
containing	NULL
both	NULL
BCL-6+*/	NULL
syn-1~	NULL
and	NULL
BCL-6-/syn-1*	NULL
RS	NULL
cells	NULL
,	NULL
CD40L+	NULL
T	NULL
cells	NULL
preferentially	NULL
cluster	NULL
around	NULL
BCL-6-/syn-1+*	NULL
RS	NULL
cells	NULL
.	NULL

This	NULL
model	NULL
suggests	NULL
that	NULL
CD40/	NULL
CD40L-mediated	NULL
interactions	NULL
between	NULL
tumor	NULL
and	NULL
reactive	NULL
cells	NULL
modulate	NULL
the	NULL
differentiation	NULL
of	NULL
the	NULL
neoplastic	NULL
clone	NULL
and	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
in	NULL
vitro	NULL
observation	NULL
that	NULL
CD40/	NULL
CD4OL	NULL
interactions	NULL
dow	NULL
nreg-ulate	NULL
BCL-6	NULL
in	NULL
B	NULL
cells	NULL
with	NULL
a	NULL
GC	NULL
phenotype	NULL
.	NULL

The	NULL
phenotypic	NULL
profiles	NULL
identified	NULL
by	NULL
BCL-6	NULL
,	NULL
syn-1	NULL
,	NULL
and	NULL
LMP-1	NULL
in	NULL
RS	NULL
cells	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
preferential	NULL
distribution	NULL
of	NULL
CD40L*	NULL
T	NULL
cells	NULL
around	NULL
BCL-6~-/syn-1*	NULL
RS	NULL
cells	NULL
,	NULL
are	NULL
consistent	NULL
with	NULL
in	NULL
vivo	NULL
observations	NULL
derived	NULL
from	NULL
other	NULL
lymphoma	NULL
types	NULL
and	NULL
with	NULL
experimental	NULL
evidence	NULL
gained	NULL
from	NULL
in	NULL
vitro	NULL
cellular	NULL
models	NULL
.	NULL

In	NULL
vivo	NULL
,	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
BCL-6	NULL
expression	NULL
is	NULL
mutually	NULL
exclusive	NULL
with	NULL
syn-1	NULL
and	NULL
LMP-1	NULL
also	NULL
in	NULL
the	NULL
context	NULL
of	NULL
systemic	NULL
acquired	NULL
immunodeficiency	NULL
syndrome	NULL
(	NULL
AIDS	NULL
)	NULL
-related	NULL
lymphomas	NULL
and	NULL
primary	NULL
central	NULL
nervous	NULL
system	NULL
lymphomas	NULL
(	NULL
PCNSL	NULL
)	NULL
.	NULL

'**	NULL
>	NULL
°	NULL
In	NULL
these	NULL
two	NULL
settings	NULL
,	NULL
the	NULL
BCL-6*/syn-1~/	NULL
LMP-1~	NULL
profile	NULL
associates	NULL
with	NULL
cases	NULL
displaying	NULL
a	NULL
large	NULL
non-cleaved	NULL
cell	NULL
morphology	NULL
and	NULL
reflecting	NULL
a	NULL
GC	NULL
phenotype	NULL
,	NULL
whereas	NULL
the	NULL
BCL-6~/syn-1*/LMP-1*	NULL
profile	NULL
associates	NULL
with	NULL
cases	NULL
displaying	NULL
an	NULL
immunoblastic	NULL
morphology	NULL
and	NULL
reflecting	NULL
a	NULL
post-GC	NULL
phenotype	NULL
.	NULL

In	NULL
vitro	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
CD40/	NULL
CD4O0L	NULL
signaling	NULL
is	NULL
able	NULL
to	NULL
downregulate	NULL
BCL-6	NULL
in	NULL
B	NULL
cells	NULL
with	NULL
a	NULL
GC	NULL
phenotype	NULL
.	NULL
``	NULL

A	NULL
similar	NULL
effect	NULL
is	NULL
exerted	NULL
in	NULL
vitro	NULL
also	NULL
by	NULL
LMP-1	NULL
,	NULL
which	NULL
,	NULL
in	NULL
fact	NULL
,	NULL
is	NULL
functionally	NULL
homologous	NULL
to	NULL
CD40	NULL
.	NULL

!	NULL

``	NULL
4	NULL
``	NULL
On	NULL
this	NULL
basis	NULL
,	NULL
it	NULL
may	NULL
be	NULL
postulated	NULL
that	NULL
CD40	NULL
ligation	NULL
may	NULL
be	NULL
the	NULL
major	NULL
determinant	NULL
of	NULL
the	NULL
phenotype	NULL
of	NULL
RS	NULL
cells	NULL
.	NULL

In	NULL
EBV-infected	NULL
HD	NULL
,	NULL
the	NULL
effect	NULL
mediated	NULL
by	NULL
CD40	NULL
ligation	NULL
may	NULL
be	NULL
substituted	NULL
by	NULL
RS	NULL
expression	NULL
of	NULL
LMP-1	NULL
.	NULL

According	NULL
to	NULL
this	NULL
model	NULL
,	NULL
NLPHD	NULL
retains	NULL
BCL-6	NULL
expression	NULL
and	NULL
,	NULL
consequently	NULL
,	NULL
2227	NULL
the	NULL
GC	NULL
phenotype	NULL
,	NULL
because	NULL
L	NULL
&	NULL
H	NULL
cells	NULL
are	NULL
not	NULL
exposed	NULL
to	NULL
CD40L	NULL
signaling	NULL
.	NULL

Conversely	NULL
,	NULL
CD40/CD40L	NULL
interactions	NULL
and/or	NULL
LMP-1	NULL
expression	NULL
induce	NULL
RS	NULL
cells	NULL
of	NULL
CHD	NULL
to	NULL
downregulate	NULL
BCL-6	NULL
,	NULL
thus	NULL
allowing	NULL
further	NULL
maturation	NULL
of	NULL
the	NULL
tumor	NULL
clone	NULL
to	NULL
assume	NULL
a	NULL
post-GC	NULL
phenotypic	NULL
profile	NULL
.	NULL

Presumably	NULL
,	NULL
cases	NULL
of	NULL
CHD	NULL
containing	NULL
a	NULL
mixture	NULL
of	NULL
BCL-6~/syn-1*	NULL
and	NULL
BCL-6+*/	NULL
syn-1~	NULL
RS	NULL
cells	NULL
represent	NULL
tumors	NULL
in	NULL
which	NULL
,	NULL
for	NULL
unknown	NULL
reasons	NULL
,	NULL
the	NULL
differentiation	NULL
process	NULL
of	NULL
RS	NULL
cells	NULL
is	NULL
not	NULL
complete	NULL
in	NULL
a	NULL
fraction	NULL
of	NULL
cells	NULL
and/or	NULL
is	NULL
still	NULL
ongoing	NULL
at	NULL
the	NULL
time	NULL
of	NULL
observation	NULL
.	NULL

ACKNOWLEDGMENT	NULL
The	NULL
authors	NULL
thank	NULL
Ivana	NULL
Zanette	NULL
,	NULL
Paola	NULL
Ceolin	NULL
,	NULL
and	NULL
Barbara	NULL
Canal	NULL
for	NULL
excellent	NULL
technical	NULL
assistance	NULL
in	NULL
immunohistochemistry	NULL
experiments	NULL
,	NULL
multiple	NULL
immunocytochemical	NULL
staining	NULL
,	NULL
and	NULL
EBER	NULL
in	NULL
situ	NULL
hybridization	NULL
studies	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Harris	NULL
NL	NULL
,	NULL
Jaffe	NULL
ES	NULL
,	NULL
Stein	NULL
H	NULL
,	NULL
Banks	NULL
PM	NULL
,	NULL
Chan	NULL
JKC	NULL
,	NULL
Cleary	NULL
ML	NULL
,	NULL
Delsol	NULL
G	NULL
,	NULL
De	NULL
Wolf-Peeters	NULL
C	NULL
,	NULL
Falini	NULL
B	NULL
,	NULL
Gatter	NULL
KC	NULL
,	NULL
Grogan	NULL
TM	NULL
,	NULL
Isaacson	NULL
PG	NULL
,	NULL
Knowles	NULL
DM	NULL
,	NULL
Mason	NULL
DY	NULL
,	NULL
Muller-Hermelink	NULL
H-K	NULL
,	NULL
Pileri	NULL
SA	NULL
,	NULL
Piris	NULL
MA	NULL
,	NULL
Ralfkiaer	NULL
E	NULL
,	NULL
Warnke	NULL
RA	NULL
:	NULL
A	NULL
revised	NULL
European-American	NULL
classification	NULL
of	NULL
lymphoid	NULL
neoplasms	NULL
:	NULL
A	NULL
proposal	NULL
from	NULL
the	NULL
International	NULL
Lymphoma	NULL
Study	NULL
Group	NULL
.	NULL

Blood	NULL
84:1361	NULL
,	NULL
1994	NULL
2	NULL
.	NULL

Gruss	NULL
H-J	NULL
,	NULL
Pinto	NULL
A	NULL
,	NULL
Duyster	NULL
J	NULL
,	NULL
Poppema	NULL
S	NULL
,	NULL
Hermann	NULL
F	NULL
:	NULL
Hodgkin	NULL
's	NULL
disease	NULL
:	NULL
A	NULL
tumor	NULL
with	NULL
disturbed	NULL
immunological	NULL
pathways	NULL
.	NULL

Immunol	NULL
Today	NULL
18:156	NULL
,	NULL
1997	NULL
3	NULL
.	NULL

Stein	NULL
H	NULL
,	NULL
Hummel	NULL
M	NULL
,	NULL
Diirkop	NULL
H	NULL
,	NULL
Foss	NULL
H-D	NULL
,	NULL
Herbst	NULL
H	NULL
;	NULL
Biology	NULL
of	NULL
Hodgkin	NULL
's	NULL
disease	NULL
,	NULL
in	NULL
Canellos	NULL
GP	NULL
,	NULL
Lister	NULL
TA	NULL
,	NULL
Sklar	NULL
JL	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
The	NULL
Lymphomas	NULL
.	NULL

Philadelphia	NULL
,	NULL
PA	NULL
,	NULL
Saunders	NULL
,	NULL
1998	NULL
,	NULL
p	NULL
287	NULL
4	NULL
.	NULL

DeVita	NULL
VT	NULL
Jr	NULL
,	NULL
Mauch	NULL
PM	NULL
,	NULL
Harris	NULL
NL	NULL
:	NULL
Hodgkin	NULL
's	NULL
disease	NULL
,	NULL
in	NULL
De	NULL
Vita	NULL
VT	NULL
Jr	NULL
,	NULL
Hellman	NULL
S	NULL
,	NULL
Rosemberg	NULL
SA	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
Cancer	NULL
Principles	NULL
&	NULL
Practice	NULL
of	NULL
Oncology	NULL
(	NULL
ed	NULL
5	NULL
)	NULL
.	NULL

Philadelphia	NULL
,	NULL
PA	NULL
,	NULL
Lippincott-Raven	NULL
,	NULL
1997	NULL
,	NULL
p	NULL
2242	NULL
5	NULL
.	NULL

Kippers	NULL
R	NULL
,	NULL
Rajewsky	NULL
K	NULL
,	NULL
Zhao	NULL
M	NULL
,	NULL
Simons	NULL
G	NULL
,	NULL
Laumann	NULL
R	NULL
,	NULL
Fischer	NULL
R	NULL
,	NULL
Hansmann	NULL
M-L	NULL
:	NULL
Hodgkin	NULL
disease	NULL
:	NULL
Hodgkin	NULL
and	NULL
Reed-Stemberg	NULL
cells	NULL
picked	NULL
from	NULL
histological	NULL
sections	NULL
show	NULL
clonal	NULL
immunoglobulin	NULL
gene	NULL
rearrangements	NULL
and	NULL
appear	NULL
to	NULL
be	NULL
derived	NULL
from	NULL
B	NULL
cells	NULL
at	NULL
various	NULL
stages	NULL
of	NULL
development	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
91:10962	NULL
,	NULL
1994	NULL
6	NULL
.	NULL

Hummel	NULL
M	NULL
,	NULL
Ziemann	NULL
K	NULL
,	NULL
Lammert	NULL
H	NULL
,	NULL
Pileri	NULL
S	NULL
,	NULL
Sabattini	NULL
E	NULL
,	NULL
Stein	NULL
H	NULL
:	NULL
Hodgkin	NULL
's	NULL
disease	NULL
with	NULL
monoclonal	NULL
and	NULL
polyclonal	NULL
populations	NULL
of	NULL
Reed-Sternberg	NULL
cells	NULL
.	NULL

N	NULL
Engl	NULL
J	NULL
Med	NULL
333:901	NULL
,	NULL
1995	NULL
7	NULL
.	NULL

Kanzler	NULL
H	NULL
,	NULL
Kiippers	NULL
R	NULL
,	NULL
Hansmann	NULL
M-L	NULL
,	NULL
Rajewsky	NULL
K	NULL
:	NULL
Hodgkin	NULL
and	NULL
Reed-Stemmberg	NULL
cells	NULL
in	NULL
Hodgkin	NULL
's	NULL
disease	NULL
represent	NULL
the	NULL
outgrowth	NULL
of	NULL
a	NULL
dominant	NULL
tumor	NULL
clone	NULL
derived	NULL
from	NULL
(	NULL
crippled	NULL
)	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
184:1495	NULL
,	NULL
1996	NULL
8	NULL
.	NULL

Marafioti	NULL
T	NULL
,	NULL
Hummel	NULL
M	NULL
,	NULL
Anagnostopoulos	NULL
I	NULL
,	NULL
Foss	NULL
HD	NULL
,	NULL
Falini	NULL
B	NULL
,	NULL
Delsol	NULL
G	NULL
,	NULL
Isaacson	NULL
PG	NULL
,	NULL
Pileri	NULL
S	NULL
,	NULL
Stein	NULL
H	NULL
:	NULL
Origin	NULL
of	NULL
nodular	NULL
lymphocyte-predominant	NULL
Hodgkin	NULL
's	NULL
disease	NULL
from	NULL
a	NULL
clonal	NULL
expansion	NULL
of	NULL
higly	NULL
mutated	NULL
germinal-center	NULL
B-cells	NULL
.	NULL

N	NULL
Engl	NULL
!	NULL

J	NULL
Med	NULL
337:453	NULL
,	NULL
1997	NULL
9	NULL
.	NULL

Ohno	NULL
T	NULL
,	NULL
Stribley	NULL
JA	NULL
,	NULL
Wu	NULL
G	NULL
,	NULL
Hinrichs	NULL
SH	NULL
,	NULL
Weisenburger	NULL
DD	NULL
,	NULL
Chan	NULL
WC	NULL
:	NULL
Clonality	NULL
in	NULL
nodular	NULL
lymphocyte-predominant	NULL
Hodgkin	NULL
's	NULL
disease	NULL
.	NULL

N	NULL
Eng	NULL
!	NULL

J	NULL
Med	NULL
337:459	NULL
,	NULL
1997	NULL
10	NULL
.	NULL

Carbone	NULL
A	NULL
,	NULL
Gaidano	NULL
G	NULL
,	NULL
Gloghini	NULL
A	NULL
,	NULL
Larocca	NULL
LM	NULL
,	NULL
Capello	NULL
D	NULL
,	NULL
Canzonieri	NULL
V	NULL
,	NULL
Antinori	NULL
A	NULL
,	NULL
Tirelli	NULL
U	NULL
,	NULL
Falini	NULL
B	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
Differential	NULL
expression	NULL
of	NULL
BCL-6	NULL
,	NULL
CD138/syndecan-1	NULL
,	NULL
and	NULL
Epstein-Barr	NULL
virus-encoded	NULL
latent	NULL
membrane	NULL
protein-1	NULL
identifies	NULL
distinct	NULL
histogenetic	NULL
subsets	NULL
of	NULL
acquired	NULL
immunodeficiency	NULL
syndrome-related	NULL
non-Hodgkin	NULL
's	NULL
lymphomas	NULL
.	NULL

Blood	NULL
91:747	NULL
,	NULL
1998	NULL
11	NULL
.	NULL

Ye	NULL
BH	NULL
,	NULL
Lista	NULL
F	NULL
,	NULL
Lo	NULL
Coco	NULL
F	NULL
,	NULL
Knowles	NULL
DM	NULL
,	NULL
Offit	NULL
K	NULL
,	NULL
Chaganti	NULL
RSK	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
Alterations	NULL
of	NULL
a	NULL
zinc	NULL
finger-encoding	NULL
gene	NULL
,	NULL
BCL-6	NULL
,	NULL
in	NULL
diffuse	NULL
large-cell	NULL
lymphoma	NULL
.	NULL

Science	NULL
262:747	NULL
,	NULL
1993	NULL
12	NULL
.	NULL

Cattoretti	NULL
G	NULL
,	NULL
Chang	NULL
C-C	NULL
,	NULL
Cechova	NULL
K	NULL
,	NULL
Zhang	NULL
J	NULL
,	NULL
Ye	NULL
BH	NULL
,	NULL
Falini	NULL
B	NULL
,	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2228	NULL
Louie	NULL
DC	NULL
,	NULL
Offit	NULL
K	NULL
,	NULL
Chaganti	NULL
RSK	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
BCL-6	NULL
protein	NULL
is	NULL
expressed	NULL
in	NULL
germinal-center	NULL
B	NULL
cells	NULL
.	NULL

Blood	NULL
86:45	NULL
,	NULL
1995	NULL
13	NULL
.	NULL

Dent	NULL
AL	NULL
,	NULL
Shaffer	NULL
AL	NULL
,	NULL
Yu	NULL
X	NULL
,	NULL
Allman	NULL
D	NULL
,	NULL
Staudt	NULL
LM	NULL
:	NULL
Control	NULL
of	NULL
inflammation	NULL
,	NULL
cytokine	NULL
expression	NULL
,	NULL
and	NULL
germinal	NULL
center	NULL
formation	NULL
by	NULL
BCL-6	NULL
.	NULL

Science	NULL
276:589	NULL
,	NULL
1997	NULL
14	NULL
.	NULL

Ye	NULL
BH	NULL
,	NULL
Cattoretti	NULL
G	NULL
,	NULL
Shen	NULL
Q	NULL
,	NULL
Zhang	NULL
J	NULL
,	NULL
Hawe	NULL
N	NULL
,	NULL
de	NULL
Waard	NULL
R	NULL
,	NULL
Leung	NULL
C	NULL
,	NULL
Nouri-Shirazi	NULL
M	NULL
,	NULL
Orazi	NULL
A	NULL
,	NULL
Chaganti	NULL
RS	NULL
,	NULL
Rothman	NULL
P	NULL
,	NULL
Stall	NULL
AM	NULL
,	NULL
Pandolfi	NULL
PP	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
The	NULL
BCL-6	NULL
proto-oncogene	NULL
controls	NULL
germinal-centre	NULL
formation	NULL
and	NULL
Th2-type	NULL
inflammation	NULL
.	NULL

Nature	NULL
Genet	NULL
16:161	NULL
,	NULL
1997	NULL
15	NULL
.	NULL

Allman	NULL
D	NULL
,	NULL
Jain	NULL
A	NULL
,	NULL
Dent	NULL
A	NULL
,	NULL
Maile	NULL
RR	NULL
,	NULL
Selvaggi	NULL
T	NULL
,	NULL
Kehry	NULL
MR	NULL
,	NULL
Staudt	NULL
LM	NULL
:	NULL
BCL-6	NULL
expression	NULL
during	NULL
B-cell	NULL
activation	NULL
.	NULL

Blood	NULL
87:5257	NULL
,	NULL
1996	NULL
16	NULL
.	NULL

Niu	NULL
H	NULL
,	NULL
Ye	NULL
BH	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
Antigen-receptor	NULL
signaling	NULL
induces	NULL
MAP	NULL
kinase-mediated	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
the	NULL
BCL-6	NULL
transcription	NULL
factor	NULL
.	NULL

Genes	NULL
Dev	NULL
12:1953	NULL
,	NULL
1998	NULL
17	NULL
.	NULL

Cattoretti	NULL
G	NULL
,	NULL
Zhang	NULL
J	NULL
,	NULL
Cleary	NULL
AM	NULL
,	NULL
Lederman	NULL
S	NULL
,	NULL
Gaidano	NULL
G	NULL
,	NULL
Carbone	NULL
A	NULL
,	NULL
Chaganti	NULL
RSK	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
Downregulation	NULL
of	NULL
BCL-6	NULL
gene	NULL
expression	NULL
by	NULL
CD40	NULL
and	NULL
EBV	NULL
latent	NULL
membrane	NULL
protein-1	NULL
(	NULL
LMP-1	NULL
)	NULL
and	NULL
its	NULL
block	NULL
in	NULL
lymphoma	NULL
carrying	NULL
BCL-6	NULL
rearrangements	NULL
.	NULL

Blood	NULL
90:175a	NULL
,	NULL
1997	NULL
(	NULL
abstr	NULL
,	NULL
suppl	NULL
1	NULL
)	NULL
18	NULL
.	NULL

Bernfield	NULL
M	NULL
,	NULL
Kokenyesi	NULL
R	NULL
,	NULL
Kato	NULL
M	NULL
,	NULL
Hinkes	NULL
MT	NULL
,	NULL
Spring	NULL
J	NULL
,	NULL
Gallo	NULL
RL	NULL
,	NULL
Lose	NULL
EJ	NULL
:	NULL
Biology	NULL
of	NULL
the	NULL
syndecans	NULL
:	NULL
A	NULL
family	NULL
of	NULL
transmembrane	NULL
heparan	NULL
sulfate	NULL
proteoglycans	NULL
.	NULL

Annu	NULL
Rev	NULL
Cell	NULL
Biol	NULL
8:365	NULL
,	NULL
1992	NULL
19	NULL
.	NULL

Sanderson	NULL
RD	NULL
,	NULL
Lalor	NULL
P	NULL
,	NULL
Bernfield	NULL
M	NULL
:	NULL
B	NULL
lymphocytes	NULL
express	NULL
and	NULL
lose	NULL
syndecan	NULL
at	NULL
specific	NULL
stages	NULL
of	NULL
differentiation	NULL
.	NULL

Cell	NULL
Regul	NULL
1:27	NULL
,	NULL
1989	NULL
20	NULL
.	NULL

Ridley	NULL
RC	NULL
,	NULL
Xiao	NULL
H	NULL
,	NULL
Hata	NULL
H	NULL
,	NULL
Woodliff	NULL
J	NULL
,	NULL
Epstein	NULL
J	NULL
,	NULL
Sanderson	NULL
RD	NULL
:	NULL
Expression	NULL
of	NULL
syndecan	NULL
regulates	NULL
human	NULL
myeloma	NULL
plasma	NULL
cell	NULL
adhesion	NULL
to	NULL
type	NULL
I	NULL
collagen	NULL
.	NULL

Blood	NULL
81:767	NULL
,	NULL
1993	NULL
21	NULL
.	NULL

Wijdenes	NULL
J	NULL
,	NULL
Vooijs	NULL
WC	NULL
,	NULL
Clément	NULL
C	NULL
,	NULL
Post	NULL
J	NULL
,	NULL
Morard	NULL
F	NULL
,	NULL
Vita	NULL
N	NULL
,	NULL
Laurent	NULL
P	NULL
,	NULL
Sun	NULL
R-X	NULL
,	NULL
Klein	NULL
B	NULL
,	NULL
Dore	NULL
J-M	NULL
:	NULL
A	NULL
plasmocyte	NULL
selective	NULL
monoclonal	NULL
antibody	NULL
(	NULL
B-B4	NULL
)	NULL
recognizes	NULL
syndecan-1	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
94:318	NULL
,	NULL
1996	NULL
22	NULL
.	NULL

Mason	NULL
DY	NULL
,	NULL
Banks	NULL
PM	NULL
,	NULL
Chan	NULL
J	NULL
,	NULL
Cleary	NULL
ML	NULL
,	NULL
Delsol	NULL
G	NULL
,	NULL
de	NULL
Wolf	NULL
Peeters	NULL
C	NULL
,	NULL
Falini	NULL
B	NULL
,	NULL
Gatter	NULL
K	NULL
,	NULL
Grogan	NULL
TM	NULL
,	NULL
Harris	NULL
NL	NULL
,	NULL
Isaacson	NULL
PG	NULL
,	NULL
Jaffe	NULL
ES	NULL
,	NULL
Knowles	NULL
DM	NULL
,	NULL
Miiller-Hermelink	NULL
K	NULL
,	NULL
Pileri	NULL
S	NULL
,	NULL
Ralfkiaer	NULL
E	NULL
,	NULL
Stein	NULL
H	NULL
,	NULL
Warnke	NULL
R	NULL
:	NULL
Nodular	NULL
lymphocyte	NULL
predominance	NULL
Hodgkin	NULL
's	NULL
disease	NULL
.	NULL

A	NULL
distinct	NULL
clinicopathological	NULL
entity	NULL
.	NULL

Am	NULL
J	NULL
Surg	NULL
Pathol	NULL
18:526	NULL
,	NULL
1994	NULL
23	NULL
.	NULL

Lukes	NULL
RJ	NULL
,	NULL
Craver	NULL
LF	NULL
,	NULL
Hall	NULL
TC	NULL
,	NULL
Rappaport	NULL
H	NULL
,	NULL
Ruben	NULL
P	NULL
:	NULL
Report	NULL
of	NULL
the	NULL
nomenclature	NULL
committee	NULL
.	NULL

Cancer	NULL
Res	NULL
26:1311	NULL
,	NULL
1966	NULL
24	NULL
.	NULL

Cordell	NULL
JL	NULL
,	NULL
Falini	NULL
B	NULL
,	NULL
Erber	NULL
WN	NULL
,	NULL
Ghosh	NULL
AK	NULL
,	NULL
Abdulaziz	NULL
Z	NULL
,	NULL
MacDonald	NULL
S	NULL
,	NULL
Pulford	NULL
KAF	NULL
,	NULL
Stein	NULL
H	NULL
,	NULL
Mason	NULL
DY	NULL
:	NULL
Immuncenzymatic	NULL
labelling	NULL
of	NULL
monoclonal	NULL
antibodies	NULL
using	NULL
immune	NULL
complexes	NULL
of	NULL
alkaline	NULL
phosphatase	NULL
and	NULL
monoclonal	NULL
antialkaline	NULL
phosphatase	NULL
(	NULL
APAAP	NULL
com-plexes	NULL
)	NULL
.	NULL

J	NULL
Histochem	NULL
Cytochem	NULL
32:219	NULL
,	NULL
1984	NULL
25	NULL
.	NULL

Flenghi	NULL
L	NULL
,	NULL
Ye	NULL
BH	NULL
,	NULL
Fizzotti	NULL
M	NULL
,	NULL
Bigema	NULL
B	NULL
,	NULL
Cattoretti	NULL
G	NULL
,	NULL
Venturi	NULL
S	NULL
,	NULL
Pacini	NULL
R	NULL
,	NULL
Pileri	NULL
S	NULL
,	NULL
Lo	NULL
Coco	NULL
F	NULL
,	NULL
Pescarmona	NULL
E	NULL
,	NULL
Pelicci	NULL
P-G	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
,	NULL
Falini	NULL
B	NULL
:	NULL
A	NULL
specific	NULL
monoclonal	NULL
antibody	NULL
(	NULL
PG-B6	NULL
)	NULL
detects	NULL
expression	NULL
of	NULL
the	NULL
BCL-6	NULL
protein	NULL
in	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
147:405	NULL
,	NULL
1995	NULL
26	NULL
.	NULL

Carbone	NULL
A	NULL
,	NULL
Gloghini	NULL
A	NULL
,	NULL
Volpe	NULL
R	NULL
:	NULL
Immunchistochemistry	NULL
of	NULL
Hodgkin	NULL
and	NULL
non-Hodgkin	NULL
lymphomas	NULL
with	NULL
emphasis	NULL
on	NULL
the	NULL
diagnostic	NULL
significance	NULL
of	NULL
the	NULL
BNH	NULL
antibody	NULL
reactivity	NULL
with	NULL
anaplastic	NULL
large	NULL
cell	NULL
(	NULL
CD30	NULL
positive	NULL
)	NULL
lymphomas	NULL
.	NULL

Cancer	NULL
70:2691	NULL
,	NULL
1992	NULL
27	NULL
.	NULL

Pinto	NULL
A	NULL
,	NULL
Gloghini	NULL
A	NULL
,	NULL
Gattei	NULL
V	NULL
,	NULL
Aldinucci	NULL
D	NULL
,	NULL
Zagonel	NULL
V	NULL
,	NULL
Carbone	NULL
CARBONE	NULL
ET	NULL
AL	NULL
A	NULL
:	NULL
Expression	NULL
of	NULL
the	NULL
c-kit	NULL
receptor	NULL
in	NULL
human	NULL
lymphomas	NULL
is	NULL
restricted	NULL
to	NULL
Hodgkin	NULL
's	NULL
disease	NULL
and	NULL
CD30+	NULL
anaplastic	NULL
large	NULL
cell	NULL
lymphomas	NULL
.	NULL

Blood	NULL
83:785	NULL
,	NULL
1994	NULL
28	NULL
.	NULL

Carbone	NULL
A	NULL
,	NULL
Gaidano	NULL
G	NULL
,	NULL
Gloghini	NULL
A	NULL
,	NULL
Pastore	NULL
C	NULL
,	NULL
Saglio	NULL
G	NULL
,	NULL
Tirelli	NULL
U	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
,	NULL
Falini	NULL
B	NULL
:	NULL
BCL-6	NULL
protein	NULL
expression	NULL
in	NULL
AIDS-related	NULL
non-Hodgkin	NULL
's	NULL
lymphomas	NULL
.	NULL

Inverse	NULL
relationship	NULL
with	NULL
Epstein-Barr	NULL
virus-encoded	NULL
latent	NULL
membrane	NULL
protein-1	NULL
expression	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
150:155	NULL
,	NULL
1997	NULL
29	NULL
.	NULL

Drexler	NULL
HG	NULL
:	NULL
Recent	NULL
results	NULL
on	NULL
the	NULL
biology	NULL
of	NULL
Hodgkin	NULL
and	NULL
Reed-Sternberg	NULL
cells	NULL
.	NULL

II	NULL
.	NULL

Continuous	NULL
cell	NULL
lines	NULL
.	NULL

Leuk	NULL
Lymphoma	NULL
9:1	NULL
,	NULL
1993	NULL
30	NULL
.	NULL

Migliazza	NULL
A	NULL
,	NULL
Martinotti	NULL
S	NULL
,	NULL
Chen	NULL
W	NULL
,	NULL
Fusco	NULL
C	NULL
,	NULL
Ye	NULL
BY	NULL
,	NULL
Knowles	NULL
DM	NULL
,	NULL
Offit	NULL
K	NULL
,	NULL
Chaganti	NULL
RSK	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
Frequent	NULL
somatic	NULL
hypermutation	NULL
of	NULL
the	NULL
5	NULL
noncoding	NULL
region	NULL
of	NULL
the	NULL
BCL6	NULL
gene	NULL
in	NULL
B-cell	NULL
lymphoma	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
92:12520	NULL
,	NULL
1995	NULL
31	NULL
.	NULL

Gaidano	NULL
G	NULL
,	NULL
Carbone	NULL
A	NULL
,	NULL
Pastore	NULL
C	NULL
,	NULL
Capello	NULL
D	NULL
,	NULL
Migliazza	NULL
A	NULL
,	NULL
Gloghini	NULL
A	NULL
,	NULL
Roncella	NULL
S	NULL
,	NULL
Ferrarini	NULL
M	NULL
,	NULL
Saglio	NULL
G	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
Frequent	NULL
mutation	NULL
of	NULL
the	NULL
5°	NULL
noncoding	NULL
region	NULL
of	NULL
the	NULL
BCL-6	NULL
gene	NULL
in	NULL
acquired	NULL
immunodeficiency	NULL
syndrome-related	NULL
non-Hodgkin	NULL
's	NULL
lymphomas	NULL
.	NULL

Blood	NULL
89:3755	NULL
,	NULL
1997	NULL
32	NULL
.	NULL

Gaidano	NULL
G	NULL
,	NULL
Lo	NULL
Coco	NULL
F	NULL
,	NULL
Ye	NULL
BH	NULL
,	NULL
Shibata	NULL
D	NULL
,	NULL
Levine	NULL
AM	NULL
,	NULL
Knowles	NULL
DM	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
Rearrangements	NULL
of	NULL
the	NULL
BCL-6	NULL
gene	NULL
in	NULL
acquired	NULL
immunodeficiency	NULL
syndrome-associated	NULL
non-Hodgkin	NULL
's	NULL
lymphoma	NULL
:	NULL
Association	NULL
with	NULL
diffuse	NULL
large-cell	NULL
subtype	NULL
.	NULL

Blood	NULL
84:397	NULL
,	NULL
1994	NULL
33	NULL
.	NULL

Armitage	NULL
P	NULL
,	NULL
Berry	NULL
G	NULL
:	NULL
Statistical	NULL
Methods	NULL
in	NULL
Medical	NULL
Research	NULL
.	NULL

Oxford	NULL
,	NULL
UK	NULL
,	NULL
Blackwell	NULL
Scientific	NULL
Publications	NULL
,	NULL
1987	NULL
34	NULL
.	NULL

Falini	NULL
B	NULL
,	NULL
Bigerna	NULL
B	NULL
,	NULL
Pasqualucci	NULL
L	NULL
,	NULL
Fizzotti	NULL
M	NULL
,	NULL
Martelli	NULL
MB	NULL
,	NULL
Pileri	NULL
S	NULL
,	NULL
Pinto	NULL
A	NULL
,	NULL
Carbone	NULL
A	NULL
,	NULL
Venturi	NULL
S	NULL
,	NULL
Pacini	NULL
R	NULL
,	NULL
Cattoretti	NULL
G	NULL
,	NULL
Pescarmona	NULL
B	NULL
,	NULL
Lo	NULL
Coco	NULL
F	NULL
,	NULL
Pelicci	NULL
P-G	NULL
,	NULL
Anagnastopoulos	NULL
I	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
,	NULL
Flenghi	NULL
L	NULL
:	NULL
Distinctive	NULL
expression	NULL
pattern	NULL
of	NULL
the	NULL
BCL-6	NULL
protein	NULL
in	NULL
nodular	NULL
lymphocyte	NULL
predominance	NULL
Hodgkin	NULL
's	NULL
disease	NULL
.	NULL

Blood	NULL
87:465	NULL
,	NULL
1996	NULL
35	NULL
.	NULL

Gruss	NULL
H-J	NULL
,	NULL
Hirschstein	NULL
D	NULL
,	NULL
Wright	NULL
B	NULL
,	NULL
Ulrich	NULL
D	NULL
,	NULL
Caligiuri	NULL
MA	NULL
,	NULL
Barcos	NULL
M	NULL
,	NULL
Strockbine	NULL
L	NULL
,	NULL
Armitage	NULL
RJ	NULL
,	NULL
Dower	NULL
SK	NULL
:	NULL
Expression	NULL
and	NULL
function	NULL
of	NULL
CD40	NULL
on	NULL
Hodgkin	NULL
and	NULL
Reed-Sternberg	NULL
cells	NULL
and	NULL
the	NULL
possible	NULL
relevance	NULL
for	NULL
Hodgkin	NULL
's	NULL
disease	NULL
.	NULL

Blood	NULL
84:2305	NULL
,	NULL
1994	NULL
36	NULL
.	NULL

Kadin	NULL
ME	NULL
:	NULL
Pathology	NULL
of	NULL
Hodgkin	NULL
's	NULL
disease	NULL
.	NULL

Curr	NULL
Opinion	NULL
Oncol	NULL
6:456	NULL
,	NULL
1994	NULL
37	NULL
.	NULL

Carbone	NULL
A	NULL
,	NULL
Gloghini	NULL
A	NULL
,	NULL
Gattei	NULL
V	NULL
,	NULL
Aldinucci	NULL
D	NULL
,	NULL
Degan	NULL
M	NULL
,	NULL
De	NULL
Paoli	NULL
P	NULL
,	NULL
Zagonel	NULL
V	NULL
,	NULL
Pinto	NULL
A	NULL
:	NULL
Expression	NULL
of	NULL
functional	NULL
CD40	NULL
antigen	NULL
on	NULL
Reed-Sternberg	NULL
cells	NULL
and	NULL
Hodgkin	NULL
's	NULL
disease	NULL
cell	NULL
lines	NULL
.	NULL

Blood	NULL
85:780	NULL
,	NULL
1995	NULL
38	NULL
.	NULL

Carbone	NULL
A	NULL
,	NULL
Gloghini	NULL
A	NULL
,	NULL
Gruss	NULL
H-J	NULL
,	NULL
Pinto	NULL
A	NULL
:	NULL
CD40	NULL
ligand	NULL
is	NULL
constitutively	NULL
expressed	NULL
in	NULL
a	NULL
subset	NULL
of	NULL
T	NULL
cell	NULL
lymphomas	NULL
and	NULL
on	NULL
the	NULL
microenvironmental	NULL
reactive	NULL
T	NULL
cells	NULL
of	NULL
follicular	NULL
lymphomas	NULL
and	NULL
Hodgkin	NULL
's	NULL
disease	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
147:912	NULL
,	NULL
1995	NULL
39	NULL
.	NULL

Larocca	NULL
LM	NULL
,	NULL
Capello	NULL
D	NULL
,	NULL
Rinelli	NULL
A	NULL
,	NULL
Nori	NULL
S	NULL
,	NULL
Antinori	NULL
A	NULL
,	NULL
Gloghini	NULL
A	NULL
,	NULL
Cingolani	NULL
A	NULL
,	NULL
Migliazza	NULL
A	NULL
,	NULL
Saglio	NULL
G	NULL
,	NULL
Camilleri-Broet	NULL
S	NULL
,	NULL
Raphael	NULL
M	NULL
,	NULL
Carbone	NULL
A	NULL
,	NULL
Gaidano	NULL
G	NULL
:	NULL
The	NULL
molecular	NULL
and	NULL
phenotypic	NULL
profile	NULL
of	NULL
primary	NULL
central	NULL
nervous	NULL
system	NULL
lymphoma	NULL
identifies	NULL
distinct	NULL
categories	NULL
of	NULL
the	NULL
disease	NULL
and	NULL
is	NULL
consistent	NULL
with	NULL
histogenetic	NULL
derivation	NULL
from	NULL
germinal	NULL
center-related	NULL
B-cells	NULL
.	NULL

Blood	NULL
92:1011	NULL
,	NULL
1998	NULL
40	NULL
.	NULL

Gires	NULL
O0	NULL
,	NULL
Zimber-Strobl	NULL
U	NULL
,	NULL
Gonnella	NULL
R	NULL
,	NULL
Ueffing	NULL
M	NULL
,	NULL
Marschall	NULL
G	NULL
,	NULL
Zeidler	NULL
R	NULL
,	NULL
Pich	NULL
D	NULL
,	NULL
Hammerschmidt	NULL
W	NULL
:	NULL
Latent	NULL
membrane	NULL
protein	NULL
1	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
mimics	NULL
a	NULL
constitutively	NULL
active	NULL
receptor	NULL
molecule	NULL
.	NULL

EMBO	NULL
J	NULL
16:6131	NULL
,	NULL
1997	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blO	NULL
0d	NULL
1998	NULL
92	NULL
:	NULL
2220-2228	NULL
Expression	NULL
Status	NULL
of	NULL
BCL-6	NULL
and	NULL
Syndecan-1	NULL
Identifies	NULL
Distinct	NULL
Histogenetic	NULL
Subtypes	NULL
of	NULL
Hodgkin	NULL
's	NULL
Disease	NULL
Antonino	NULL
Carbone	NULL
,	NULL
Annunziata	NULL
Gloghini	NULL
,	NULL
Gianluca	NULL
Gaidano	NULL
,	NULL
Silvia	NULL
Franceschi	NULL
,	NULL
Daniela	NULL
Capello	NULL
,	NULL
Hans	NULL
G.	NULL
Drexler	NULL
,	NULL
Brunangelo	NULL
Falini	NULL
and	NULL
Riccardo	NULL
Dalla-Favera	NULL
4	NULL
QM	NULL
“	NULL
Caw	NULL
,	NULL
.	NULL

A	NULL
'	NULL
\se	NULL
@	NULL
.	NULL

®	NULL
``	NULL
Ctown®	NULL
@	NULL
``	NULL
20	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/92/7/2220.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

